Filed by the Registrant ☒
|
||
|
||
Filed by a Party other than the Registrant ☐
|
||
|
||
Check the appropriate box:
|
||
☐
|
|
Preliminary Proxy Statement
|
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
☒
|
|
Definitive Proxy Statement
|
|
|
|
☐
|
|
Definitive Additional Materials
|
|
|
|
☐
|
|
Soliciting Material under §240.14a-12
|
VENTAS, INC.
|
|||
(Name of Registrant as Specified In Its Charter)
|
|||
|
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|||
|
|||
Payment of Filing Fee (Check the appropriate box):
|
|||
|
|
|
|
☒
|
|
No fee required.
|
|
|
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
5)
|
Total fee paid:
|
|
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
1)
|
Amount Previously Paid:
|
|
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
3)
|
Filing Party:
|
|
|
|
|
|
|
4)
|
Date Filed:
|
|
|
|
|
|
Page
|
|
3
|
||
3
|
||
10
|
||
13
|
||
14
|
||
16
|
||
16
|
||
17
|
||
17
|
||
17
|
||
17
|
||
18
|
||
18
|
||
19
|
||
19
|
||
20
|
||
20
|
||
20
|
||
21
|
||
21
|
||
21
|
||
22
|
||
22
|
||
23
|
||
23
|
||
23
|
||
23
|
||
23
|
||
23
|
||
24
|
||
24
|
||
26
|
||
27
|
||
29
|
||
29
|
||
29
|
||
29
|
||
35
|
||
38
|
||
38
|
||
39
|
||
40
|
||
51
|
||
52
|
||
52
|
||
52
|
||
52
|
||
53
|
||
53
|
||
54
|
|
2019 PROXY STATEMENT
|
1
|
Page
|
||
54
|
||
55
|
||
56
|
||
58
|
||
58
|
||
62
|
||
65
|
||
66
|
||
66
|
||
66
|
||
67
|
||
67
|
||
68
|
||
69
|
||
70
|
||
70
|
||
71
|
||
71
|
||
72
|
||
72
|
||
80
|
||
82
|
||
85
|
||
85
|
||
86
|
||
86
|
||
87
|
||
A-1
|
|
2019 PROXY STATEMENT
|
2
|
*
|
Net debt to adjusted pro forma EBITDA and normalized FFO are not calculated according to U.S. generally accepted accounting
principles (“GAAP”), but please see Annex A for reconciliations of these performance measures to our GAAP earnings (the most directly comparable GAAP measure). In addition, please see Annex A for a discussion of how we calculate same-store
cash NOI.
|
|
2019 PROXY STATEMENT
|
3
|
|
2019 PROXY STATEMENT
|
4
|
|
2019 PROXY STATEMENT
|
5
|
|
2019 PROXY STATEMENT
|
6
|
|
2019 PROXY STATEMENT
|
7
|
|
2019 PROXY STATEMENT
|
8
|
|
2019 PROXY STATEMENT
|
9
|
|
2019 PROXY STATEMENT
|
10
|
For 2013-2016, the period during which our backward-looking plan was in effect, the graph aligns the value of long-term equity incentive awards with the
performance year for which they were earned, rather than the year in which they were granted (e.g., long-term equity incentive awards granted in January 2017 for
2016 performance are shown in the graph above as 2016 compensation), consistent with the manner in which our Compensation Board Members evaluated compensation and pay-for-performance under the previous backward-looking plan for our Named
Executive Officers.
|
|
For 2017 and 2018, the first years our new forward-looking long-term equity incentive plan was in effect, we report the grant date fair value
(approximating target level of performance) of the performance-based restricted stock units (“pRSUs”) granted in 2017 and 2018 that may be earned, if at all, based on performance relative to performance goals measured from January 1, 2017
through December 31, 2019 and January 1, 2018 through December 31, 2020, respectively. Actual payouts will occur in 2020 and 2021, respectively, and will range from 0% - 220% of the target value.
|
|
The 2017 figure excludes one-time time-based restricted stock unit (“RSU”) transition awards received by certain of our Named Executive Officers, which
were designed to partially mitigate the impact of a reduction in the realized pay for our Named Executive Officers in 2018 and 2019 resulting from the transition from a backward-looking long-term equity incentive plan to a forward-looking
plan because the new forward-looking awards do not pay out, if at all, until 2020 and later. These awards are excluded because they were one-time in nature, did not recur in 2018 or 2019 and the Compensation Committee does not view these
awards as a continuing feature of the long-term equity incentive plan.
|
|
2019 PROXY STATEMENT
|
11
|
|
2019 PROXY STATEMENT
|
12
|
Vote by Telephone: Call (800) 690-6903, 24 hours a day, seven days a week
through May 13, 2019
|
||
Vote on the Internet: Visit www.proxyvote.com, 24 hours a day, seven days a week through May 13, 2019
|
||
Vote by Mail: Request, complete and return a copy of the proxy card in the
postage-paid envelope provided
|
||
Vote in Person: Request, complete and deposit a copy of the proxy card or
complete a ballot at the Annual Meeting
|
|
2019 PROXY STATEMENT
|
13
|
Name
|
Age
|
Director
since
|
Primary Position
|
Current
Committees**
|
Principal Skills
|
Melody C. Barnes*
|
55
|
2014
|
Co-Founder and Principal of MB Squared Solutions LLC and Chair, Aspen Institute Forum for Community Solutions
|
A; N
|
Public Policy, Government Relations, Strategic Planning, Leadership Development
|
Debra A. Cafaro
|
61
|
1999
|
Chairman and CEO of Ventas
|
E; I
|
Real Estate Industry, Corporate Finance, Mergers and Acquisitions, Capital Markets, Strategic Planning
|
Jay M. Gellert*
|
65
|
2001
|
Former President and CEO of Health Net, Inc.
|
E; I; N
|
Healthcare Industry, Mergers and Acquisitions, Strategic Planning, Government Relations, Executive Compensation
|
Richard I. Gilchrist*
|
73
|
2011
|
Senior Advisor to The Irvine Company and Chairman of TIER REIT, Inc.
|
C; I
|
Real Estate Industry, Mergers and Acquisitions, Strategic Planning, Executive Compensation, Corporate Governance
|
Matthew J. Lustig*
|
58
|
2011
|
Head of North America Investment Banking and Head of Real Estate and Lodging at Lazard Frères & Co. LLC
|
E; I
|
Real Estate Industry, Corporate Finance, Mergers and Acquisitions, Capital Markets, Strategic Planning, International Transactions
|
Roxanne M. Martino*
|
62
|
2016
|
Managing Partner of OceanM19; former CEO, Partner and Investment Committee Chairperson of Aurora Investment Management L.L.C.
|
C; I
|
Corporate Finance, Mergers and Acquisitions, Capital Markets, Strategic Planning
|
Walter C. Rakowich*
|
61
|
2016
|
Former CEO of Prologis, Inc.
|
A
|
Real Estate Industry, Corporate Finance, Mergers and Acquisitions, Capital Markets, Strategic Planning
|
Robert D. Reed*
|
66
|
2008
|
Former Senior Vice President and Chief Financial Officer of Sutter Health
|
A; E
|
Healthcare Industry, Corporate Finance, Strategic Planning, Capital Intensive Operations, Pension Fund Investments
|
James D. Shelton*†
|
65
|
2008
|
Former Chairman of Omnicare, Inc.; former CEO and Chairman of Triad Hospitals, Inc.
|
C; E;
N
|
Healthcare Industry, Mergers and Acquisitions, Strategic Planning, Capital Intensive Operations, Government Relations, Executive Compensation, Corporate
Governance
|
*
|
Independent Director
|
†
|
Presiding Director
|
**
|
Abbreviations: A = Audit and Compliance; C = Executive Compensation; E = Executive; I = Investment; N = Nominating and Corporate Governance. Bold print indicates committee chair.
|
|
2019 PROXY STATEMENT
|
14
|
|
2019 PROXY STATEMENT
|
15
|
|
2019 PROXY STATEMENT
|
16
|
|
Vote your shares by proxy by calling (800) 690-6903, 24 hours a day, seven days a week until 11:59 p.m. Eastern time on May 13, 2019. Please have your
proxy card in hand when you call. The telephone voting system has easy-to-follow instructions and provides confirmation that the system has properly recorded your vote.
|
|
|
|
OR
|
|
Vote your shares by proxy via the website www.proxyvote.com, 24 hours a day,
seven days a week until 11:59 p.m. Eastern time on May 13, 2019. Please have your proxy card in hand when you access the website. The website has easy-to-follow instructions and provides confirmation that the system has properly recorded your
vote.
|
|
|
|
OR
|
|
If you have requested or receive paper copies of our proxy materials by mail, vote your shares by proxy by signing, dating and returning the proxy card in
the postage-paid envelope provided. If you vote by telephone or over the Internet, you do not need to return your proxy card by mail.
|
|
|
|
OR
|
Vote your shares by attending the Annual Meeting in person and depositing your proxy card at the registration desk (if you have requested paper copies of
our proxy materials by mail) or completing a ballot that will be distributed at the Annual Meeting.
|
|
2019 PROXY STATEMENT
|
17
|
FOR the election of all director-nominees named in this Proxy Statement (Proposal 1);
|
FOR the ratification of the selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2019 (Proposal 2);
|
FOR the approval, on an advisory basis, of our executive compensation (Proposal 3); and
|
In the discretion of the proxy holders, on such other business as may properly come before the Annual Meeting.
|
|
2019 PROXY STATEMENT
|
18
|
have demonstrated management or technical ability at high levels in successful organizations;
|
have experience relevant to our operations, such as real estate, REITs, healthcare, finance or general management;
|
be well-respected in their business and home communities;
|
have time to devote to Board duties; and
|
be independent from us and not related to our other directors or employees.
|
|
2019 PROXY STATEMENT
|
19
|
|
2019 PROXY STATEMENT
|
20
|
|
2019 PROXY STATEMENT
|
21
|
|
2019 PROXY STATEMENT
|
22
|
|
2019 PROXY STATEMENT
|
23
|
Our Audit Committee reviews financial, accounting and internal control risks and the mechanisms through which we assess and manage risk, in accordance with NYSE
requirements, and has certain responsibilities with respect to our compliance programs, such as our Global Code of Ethics and Business Conduct, our Global Anti-Corruption Policy, our Political Contributions, Expenditure and Activity Policy
and our Amended and Restated Securities Trading Policy.
|
|
2019 PROXY STATEMENT
|
24
|
Our Compensation Committee, as discussed in greater detail below, evaluates whether our compensation policies and practices, as they relate to both executive officers and
employees generally, encourage excessive risk-taking.
|
Our Nominating Committee focuses on risks related to corporate governance, board effectiveness and succession planning. Our Board has adopted an emergency succession plan to
facilitate the transition to both interim and long-term leadership in the unlikely event of an untimely vacancy in the position of Chief Executive Officer.
|
Our Investment Committee is responsible for overseeing certain transaction-related risks, including the review of transactions in excess of certain thresholds, with existing
tenants, operators, borrowers or managers, or that involve investments in non-core assets.
|
a balanced mix of cash and equity compensation with a strong emphasis on performance-based incentive awards;
|
multiple performance measures selected in the context of our business strategy and often in tension with each other, for example, goals which promote FFO growth and
maintaining a strong balance sheet;
|
regular review of comparative compensation data to maintain competitive compensation levels in light of our industry, size and performance;
|
incentive award opportunities that do not provide minimum guaranteed payouts, are based on a range of performance outcomes and are plotted along a continuum, and have capped
payouts, subject in all cases to the Compensation Committee’s and, in the case of our Chief Executive Officer, the independent Board members’ overall assessment of performance;
|
equity compensation consisting entirely of full-value awards—pRSUs and time-based RSUs—to provide greater incentive to create and preserve long-term stockholder value;
|
equity incentive awards granted for future performance with multi-year vesting schedules/performance periods to enhance retention;
|
minimum stock ownership guidelines that align executive officers with long-term stockholder interests;
|
our recoupment policy enables our Board to “claw back” incentive compensation in the event of a financial restatement; and
|
prohibitions on engaging in derivative and other hedging transactions in our securities and restrictions on holding our securities in margin accounts or otherwise pledging
our securities to secure loans.
|
|
2019 PROXY STATEMENT
|
25
|
|
2019 PROXY STATEMENT
|
26
|
|
2019 PROXY STATEMENT
|
27
|
|
2019 PROXY STATEMENT
|
28
|
Name
|
Title
|
Debra A. Cafaro
|
Chairman and Chief Executive Officer
|
Robert F. Probst
|
Executive Vice President and Chief Financial Officer
|
John D. Cobb
|
Executive Vice President and Chief Investment Officer
|
T. Richard Riney
|
Executive Vice President, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer
|
Peter J. Bulgarelli
|
Executive Vice President, Office; President and Chief Executive Officer, Lillibridge Healthcare Services, Inc.
|
|
2019 PROXY STATEMENT
|
29
|
|
Our 3.4% TSR in 2018 outperformed the S&P 500 Index and the MSCI REIT Index by nearly eight percentage points. Our TSR also outperformed the MSCI REIT Index and the FTSE
NAREIT Equity Health Care Index for the three-, five- and 10-year periods ended December 31, 2018, demonstrating short- and long-term outperformance during varied economic cycles.
|
|
For the period from January 1, 2000 through December 31, 2018 (the 19 full fiscal years of our Chief Executive Officer’s tenure), we delivered compound annual TSR of 23%,
dramatically outperforming our peers, the S&P 500 Index and the MSCI REIT Index.
|
|
We increased our dividend in 2018, marking our 9th consecutive year of dividend growth.
|
|
2019 PROXY STATEMENT
|
30
|
Normalized FFO and Same-Store Cash NOI Growth:
|
|
Our high quality and diverse portfolio of assets delivered normalized FFO of $4.07 and same-store cash NOI growth of 1.2%;
|
|
|
Effective Balance Sheet Management and Efficient Capital Markets Execution:
|
|
|
|
Further strengthened our financial condition by refinancing or repaying $3.5 billion of debt, thereby extending our debt maturity profile by 0.7x to 7.0 years
and minimizing intermediate-term interest rate exposure, including the renewal and extension of our $900 million term loan at improved pricing, proactive issuance of $1.4 billion in new 10-year senior notes at attractive pricing and effective
execution and maintenance of our BBB+ credit rating and strong balance sheet with a 5.6x net debt to adjusted pro forma EBITDA ratio and a fixed charge coverage ratio of 4.6x;
|
Profitable Dispositions:
|
|
Continued our strategic and highly profitable disposition program, harvesting $1.3 billion in proceeds from profitable investments, including the timely receipt
of (a) greater than $900 million repayments of well-structured and high unlevered IRR loans and (b) proceeds from the sale of non-core properties at an average 6% yield, redeploying the proceeds into future growth opportunities and
improvement of our balance sheet;
|
|
Value-Creating Investments:
|
|
Made investments of $800 million at a blended 7.5% cash yield to further improve the quality of our portfolio, including an acquisition of a premier independent
living seniors housing community located in the appealing Battery Park neighborhood of downtown Manhattan;
|
|
Research & Innovation Business Growth:
|
|
Elevated and expanded our Research & Innovation Business (grown by 45% since inception) with the nation’s leading research universities and created a $1.5
billion development pipeline consisting of near-term projects with new and existing university relationships;
|
|
Successful Operator and Partner Collaborations:
|
|
Successful negotiation of collaborative and mutually beneficial arrangements with several of our operators and partners, including lease extensions with
Brookdale and a 10-year extension of our exclusive MOB development relationship with PMB, which has nearly 50 years of experience in MOB development with top health systems in the U.S.;
|
|
Sustainability, Values, Reputation and Industry Leadership:
|
|
Published our high quality and well-received inaugural Corporate Sustainability Report, which provides transparency on our ESG outcomes, actions and policies;
|
|
We were named among Fortune’s “World’s Most Admired Companies” and received numerous prestigious awards in 2018 in recognition of our philanthropy, reputation,
commitment to superior governance and results, industry leaders, exemplary stewardship and world-class team;
|
|
First REIT signatory to the CEO Action for Diversity & Inclusion™ pledge, a cross-industry CEO-driven business commitment to advance diversity and inclusion
in the workplace, and unconscious bias training was conducted for all employees;
|
|
Established and made public our Vendor Code of Conduct and Human Rights Policy;
|
|
Continued to build an industry-leading portfolio of 72 ENERGY STAR Certified buildings and 38 LEED Certified buildings, which includes more than $430 million of
investment in 8 active developments pursuing LEED certification and receipt of a broad range of awards and recognitions during the year in REIT space, healthcare industry and among global corporations, including inclusion in the Dow Jones
Sustainability Index (attaining top quartile results across ESG metrics among all North American real estate companies), achieving the #1 rank among public Healthcare REITs in the 2018 GRESB Real Estate Assessment on Sustainability and
representation in the FTSE4GOOD Sustainability Index Series;
|
|
2019 PROXY STATEMENT
|
31
|
Identified as a “Winning Company” in the 2020 Women on Boards Gender Diversity Index and a “Corporate Champion” by the Women’s Forum of New York for having an
industry-leading 33% female Board of Directors;
|
|
Ventas Charitable Foundation contributed greater than $900,000 to 78 organizations in 2018, including our ongoing 5-year, $1 million marquee partnership with
the Greater Chicago Food Depository to alleviate senior hunger; and
|
|
Greater than 90 percent of requests have been met and in excess of $670,000 given to an Employee Charitable Fund, which
provides grants to organizations that are directly nominated by our employees.
|
|
2019 PROXY STATEMENT
|
32
|
|
For 2013-2016, the period during which our backward-looking plan was in effect, the graph aligns the value of long-term equity incentive awards with the performance year for
which they were earned, rather than the year in which they were granted (e.g., long-term equity incentive awards granted in January 2017 for 2016 performance are shown in the graph
above as 2016 compensation), consistent with the manner in which our Compensation Board Members evaluated compensation and pay-for-performance under the previous backward-looking plan for our Named Executive Officers.
|
|
2019 PROXY STATEMENT
|
33
|
|
For 2017 and 2018, the first years our new forward-looking long-term equity incentive plan was in effect, we report the grant date fair value (approximating target level of
performance) of the pRSUs granted in 2017 and 2018 that may be earned, if at all, based on performance relative to performance goals measured from January 1, 2017 through December 31, 2019 and January 1, 2018 through December 31, 2020,
respectively. Actual payouts will occur in 2020 and 2021, respectively, and will range from 0% - 220% of the target value.
|
|
The 2017 figure excludes one-time time-based restricted stock unit (“RSU”) transition awards received by certain of our Named Executive Officers, which were designed to partially
mitigate the impact of a reduction in the realized pay for our Named Executive Officers in 2018 and 2019 resulting from the transition from a backward-looking long-term equity incentive plan to a forward-looking plan because the new
forward-looking awards do not pay out, if at all, until 2020 and later. These awards are excluded because they were one-time in nature, did not recur in 2018 or 2019 and the Compensation Committee does not view these awards as a continuing
feature of the long-term equity incentive plan.
|
Compensation Policies and Practices—Good Governance |
|
Balance: The structure of our executive compensation program includes a balanced mix of cash and equity compensation with a strong emphasis on performance-based incentive awards that contain a blend of metrics promoting
responsible growth and risk management.
|
|
Capped Opportunity: Our Named Executive Officers’ incentive award opportunities are capped, and the value of their awards is determined based on the Compensation Committee’s or the independent Board members’ assessment of performance
with respect to multiple performance measures, including relative TSR, that promote stockholder value.
|
|
Retention:
The long-term equity incentive awards granted to our Named Executive Officers measure future performance over a three-year period to enhance retention and alignment with long-term
stockholder value.
|
|
Peer Companies:
The competitiveness of our executive compensation program is assessed by comparison to the median of a group of peer companies that are comparable to us in terms of enterprise value,
market capitalization and total assets.
|
|
Independence:
Our Compensation Committee is comprised solely of independent directors and annually engages an independent compensation consultant to advise on matters related to our executive
compensation program.
|
|
Change of Control: Our employment agreements and all forward-looking equity award agreements with executive officers do not provide single-trigger change of control benefits,
and we prohibit new tax gross-up arrangements under our anti-tax gross-up policy. Only one of our Named Executive Officers has a legacy agreement with a tax gross-up provision.
|
Stock Ownership Guidelines: We maintain meaningful stock ownership guidelines for our executive officers and non-employee directors that promote a long-term stockholder perspective.
|
|
Risk Review:
Our Compensation Committee annually reviews and assesses the potential risks of our compensation policies and practices for all employees.
|
|
Clawback Policy:
Our recoupment policy enables our Board to “claw back” incentive compensation in the event of a financial restatement.
|
|
Limited Perquisites: Our executive officers receive limited perquisites and other personal benefits that are not otherwise generally available to all of our employees.
|
|
|
No Pledging or Hedging: Our Amended and Restated Securities Trading Policy (“Securities Trading Policy”) prohibits our executive officers and directors from engaging in derivative
and other hedging transactions in our securities and restricts our executive officers and directors from holding our securities in margin accounts or otherwise pledging our securities to secure loans without the prior approval of the Audit
Committee (no executive officer or director pledged or held our securities in margin accounts at any time during 2018).
|
|
2019 PROXY STATEMENT
|
34
|
|
2019 PROXY STATEMENT
|
35
|
|
Based on these discussions, we learned that our stockholders generally:
|
|
approve of the overall structure of our executive compensation program and diversity of goals, particularly our use of balanced metrics of growth, risk management and capital
structure to mitigate risk and promote responsible, sustained long-term growth;
|
approve of our implementation of the executive compensation program, the factors considered and the decisions made under the program;
|
|
approve of our proxy disclosures regarding our executive compensation program and corporate governance best practices;
|
|
support our pay-for-performance alignment; and
|
|
endorse our corporate governance practices.
|
|
2019 PROXY STATEMENT
|
36
|
|
2019 PROXY STATEMENT
|
37
|
attract, retain and motivate talented executives;
|
|
reward performance that meets or exceeds pre-established company and tailored individual goals consistent with our strategic plan, while maintaining alignment with stockholders;
|
|
provide balanced incentives that discourage excessive risk-taking;
|
|
retain sufficient flexibility to permit our executive officers to manage risk and adjust appropriately to meet rapidly changing market and business conditions;
|
|
evaluate performance by balancing consideration of those measures that management can directly and significantly influence with market forces that management cannot control (such
as monetary policy and interest rate expectations), but that impact stockholder value;
|
|
encourage executives to become and remain long-term stockholders of our company; and
|
|
maintain compensation and corporate governance practices that support our goal to deliver sustained, superior returns to stockholders.
|
|
2019 PROXY STATEMENT
|
38
|
2018 Comparable Companies
|
|
American Tower Corp.
|
AvalonBay Communities, Inc.
|
Boston Properties, Inc.
|
Crown Castle International Corp.
|
Digital Realty Trust, Inc.
|
Equinix, Inc.
|
Equity Residential
|
GGP Inc.
|
HCP, Inc.
|
Prologis, Inc.
|
Public Storage, Inc.
|
Realty Income Corp.
|
Simon Property Group, Inc.
|
SL Green Realty Group, Inc.
|
The Macerich Company
|
Vornado Realty Trust, Inc.
|
Welltower, Inc.
|
Weyerhaeuser Co.
|
|
2019 PROXY STATEMENT
|
39
|
|
Base Salary
|
Year-Over-Year
% Change
|
||||
|
2017
|
2018
|
||||
Debra A. Cafaro
|
$ 1,075,000
|
$ 1,075,000
|
0%
|
|||
Robert F. Probst
|
615,000
|
627,300
|
2.0%
|
|||
John D. Cobb
|
605,000
|
626,175
|
3.5%
|
|||
T. Richard Riney
|
560,000
|
571,200
|
2.0%
|
|||
Peter J. Bulgarelli
|
—
|
450,000
|
—
|
|
Base Salary
|
Year-Over-Year
% Change
|
|||
|
2018
|
2019
|
|||
Debra A. Cafaro
|
$ 1,075,000
|
$ 1,075,000
|
0%
|
||
Robert F. Probst
|
627,300
|
646,119
|
3.0%
|
||
John D. Cobb
|
626,175
|
644,960
|
3.0%
|
||
T. Richard Riney
|
571,200
|
576,912
|
1.0%
|
||
Peter J. Bulgarelli
|
450,000
|
468,000
|
4.0%
|
|
2019 PROXY STATEMENT
|
40
|
|
2019 PROXY STATEMENT
|
41
|
Threshold
|
$3.95
|
Target
|
$4.00
|
Maximum
|
$4.05
|
|
2019 PROXY STATEMENT
|
42
|
Threshold
|
3.75x
|
Target
|
4.00x
|
Maximum
|
4.25x
|
Threshold
|
$1 billion
|
Target
|
$1.75 billion
|
Maximum
|
$2.5 billion
|
|
2019 PROXY STATEMENT
|
43
|
MOB Measure
|
Achievement
|
Goal
|
Weighting
|
Same-Store MOB Cash NOI
|
Threshold
|
1.0%
|
40%
|
Target
|
1.5%
|
||
Maximum
|
2.0%
|
||
Same-Store Occupancy
|
Threshold
|
91.0%
|
30%
|
Target
|
91.5%
|
||
Maximum
|
92.0%
|
||
Non-Same Store MOB Cash NOI
|
Threshold
|
$36.62 million
|
10%
|
Target
|
$37.59 million
|
||
Maximum
|
$38.55 million
|
||
Cash Leasing Spread
|
Threshold
|
-1.0%
|
10%
|
Target
|
0.0%
|
||
Maximum
|
1.0%
|
||
FAD Capital Expenditures
|
Threshold
|
≤ $55.0 million
|
10%
|
Target
|
≤ $53.5 million
|
||
Maximum
|
≤ $52.0 million
|
|
2019 PROXY STATEMENT
|
44
|
Name
|
Accomplishments
|
|
Debra A. Cafaro
|
✓
|
Drove delivery of 3.4% TSR in 2018, outperforming the S&P 500 Index and the MSCI REIT Index by nearly eight percentage points and
the MSCI REIT Index and the FTSE NAREIT Equity Health Care Index for the three-, five- and 10-year periods ended December 31, 2018.
|
|
✓
|
Oversaw the delivery of strong financial results, including:
a. normalized FFO of $4.07 and
b. same-store cash NOI growth of
1.2%.
|
✓
|
Oversaw improved financial strength and flexibility, and management of intermediate term interest rate and maturity schedule risk,
including:
a. 5.6x net debt to adjusted
pro forma EBITDA,
b. 4.6x fixed charge coverage
and
c. refinancing/repayment of $3.5
billion of debt, including issuance of $1.4 billion in 10 year fixed senior notes and renewal and extension of our $900 million term loan at improved pricing.
|
|
|
✓
|
Continued emphasis on portfolio reshaping and quality enhancement through:
a. the timely receipt of (i)
greater than $900 million repayments of well-structured and high unlevered IRR loans and (ii) proceeds from the sale of non-core properties at an average 6% yield, and
b. redeployment
of proceeds into future growth opportunities and improvement of our balance sheet.
|
|
✓
|
Oversaw strategy evolution with focus on high quality university-based Research & Innovation business, and other key initiatives
geared toward growth and strength. Utilized extensive networks and external policy contacts to inform Ventas strategy and investments.
|
|
✓
|
Retained and motivated excellent team, including recruitment and onboarding of new Office leader. Emphasized performance, positive
culture, cohesion and forward focus on growth and financial strength.
|
|
✓
|
Oversaw successful negotiation of collaborative and mutually beneficial arrangements with several of our operators and partners,
including Brookdale lease amendments, Kindred “go private” and a 10-year extension of our exclusive MOB development relationship with PMB, which has nearly 50 years of experience in MOB development with top health systems in the U.S.
|
|
✓
|
Elevated our ESG efforts and profile, including issuance of our high quality and well-received inaugural Corporate Sustainability
Report, being the first REIT signatory to the CEO Action for Diversity & Inclusion™ pledge, being identified as a “Winning Company” in the 2020 Women on Boards Gender Diversity Index and a “Corporate Champion” by the Women’s Forum of New
York for having an industry-leading 33% female Board of Directors, inclusion in the Dow Jones Sustainability Index (attaining top quartile results across ESG metrics among all North American real estate companies), achieving the #1 rank among
public Healthcare REITs in the 2018 GRESB Real Estate Assessment on Sustainability, recipient of the NAREIT Health Care “Leader in the Light” Award for the third time and representation in the FTSE4GOOD Sustainability Index Series.
|
|
✓
|
Earned numerous prestigious recognitions, including being named a Top 100 CEOs in the World by the Harvard Business Review (1 of only
18 named five consecutive years), 100 Most Influential People in Healthcare by Modern Healthcare (four years) and elected as Chair of Real Estate Roundtable by leaders in the industry.
|
|
2019 PROXY STATEMENT
|
45
|
Robert F. Probst
|
✓
|
Drove the delivery of strong financial results through careful management of Company resources, including:
a. normalized FFO of $4.07 and
b. same-store cash NOI growth
of 1.2%.
|
✓
|
Oversaw improved financial strength and flexibility, and management of intermediate term interest rate and maturity schedule risk,
including:
a. 5.6x net debt to adjusted
pro forma EBITDA,
b. 4.6x fixed charge coverage
and
c. refinancing/repayment of
$3.5 billion of debt, including issuance of $1.4 billion in 10 year fixed senior notes and renewal and extension of our $900 million term loan at improved pricing.
|
|
✓
|
Built enhanced teams in IT, Finance and Senior Living Asset Management and recruited and onboarded internal and external top talent and
significantly upgraded capabilities.
|
|
✓
|
Outstanding external communication with stakeholders, especially regarding senior housing market conditions.
|
|
|
✓
|
Improved capital expenditures management and accounting functions.
|
✓
|
Significant investment in senior housing data analytics and resources to provide insight generation and enhanced decision-making
capabilities.
|
|
✓
|
Led strategic process to evolve firm strategy with significant contributions in senior housing thought leadership and developing our
competitive position and growth opportunities in our university-based Research & Innovation business.
|
|
|
✓
|
Recognized as the 2018 Chicago Public Company CFO of the Year by the Financial Executives International Chicago Chapter.
|
John D. Cobb
|
✓
|
Led team to make $800 million of attractive, value-creating investments at a blended 7.5% cash yield, including an acquisition of a
premier independent living seniors housing community located in the appealing Battery Park neighborhood of downtown Manhattan.
|
|
✓
|
Effective oversight and management of active development and redevelopment projects across all asset classes, including continued
growth in our university-based Research & Innovation business with significant developments and acquisitions (grown by 45% since inception with a strong pipeline of opportunities). Built and accelerated a strong pipeline of Research &
Innovation projects.
|
✓
|
Received $1.3 billion in disposition proceeds and loan repayments, including timely receipt of (a) greater than $900 million repayments
of well-structured and high unlevered IRR loans and (b) proceeds from the sale of non-core properties at an average 6% yield.
|
|
✓
|
Key role in negotiating mutually beneficial arrangements with several of our operators to protect stockholder value and foster positive
customer relationships, including lease amendments with Brookdale and a 10-year extension of our exclusive MOB development relationship with PMB, which has nearly 50 years of experience in MOB development with top health systems in the U.S.
|
|
✓
|
Reorganized Investments team to enhance focus on Research & Innovation and other targeted business segments.
|
|
✓
|
Created and oversaw team to evaluate Chicago office space market.
|
|
✓
|
Effective transition of assets to Eclipse Senior Living, a newly formed operator, on an accelerated timeline.
|
|
T. Richard Riney
|
✓
|
Led and managed all legal aspects of investments, divestitures and collaborative and mutually beneficial arrangements with several of
our operators.
|
✓
|
Improved and streamlined risk management review function.
|
|
✓
|
Drove superior same-store cash NOI growth in triple-net healthcare business.
|
|
✓
|
Reorganized triple-net healthcare team and improved talent.
|
|
|
✓
|
Implemented customer-focused process initiatives to enhance the triple-net customer experience.
|
|
✓
|
Optimized risk management through key improvements to our policies and procedures, including improved enterprise risk management
program.
|
|
✓
|
Enhanced company-wide Integrity and Compliance program.
|
Peter J. Bulgarelli
|
✓
|
Decisively and effectively assumed management of our growing Office segment.
|
✓
|
Increased leasing focus and tenant retention within MOB segment, resulting in record leasing volume.
Efficiently controlled operating expenses.
|
|
✓
|
Implemented customer relationship management program and another initiatives to drive customer satisfaction.
|
|
|
✓
|
Enhanced data analytics capabilities.
|
✓
|
Restaffed Office asset management and FP&A functions and streamlined reporting processes.
|
|
✓
|
Became initial executive sponsor of newly created Asset Management Leadership Council.
|
|
|
✓
|
Served on Ardent board during crucial time of IPO preparation and decision-making.
|
|
2019 PROXY STATEMENT
|
46
|
Named Executive Officer
|
Threshold Opportunity
|
Target Opportunity
|
Maximum Opportunity
|
Actual Payout
|
Debra A. Cafaro
|
$ 1,290,000
|
$ 2,150,000
|
$ 3,870,000
|
$ 3,749,600
|
Robert F. Probst
|
784,125
|
1,097,775
|
1,568,250
|
1,518,850
|
John D. Cobb
|
782,719
|
1,095,806
|
1,565,438
|
1,516,126
|
T. Richard Riney
|
714,000
|
999,600
|
1,428,000
|
1,338,036
|
Peter J. Bulgarelli
|
450,000
|
675,000
|
900,000
|
752,8241
|
|
2019 PROXY STATEMENT
|
47
|
Forward-Looking Rather than Retrospective. The 2018 long-term equity incentive compensation program is prospective instead of
retrospective. Performance-based awards will be earned at a higher or lower level (including zero payout) based on future performance, rather than being granted following the satisfaction of specified performance goals.
|
|
No Qualitative or Discretionary Goals. Consistent with investor feedback, qualitative or discretionary goals, which comprised 50%
of the award opportunity under the program prior to 2017, are completely eliminated.
|
|
Three-Year Measurement Periods. All performance-based award performance periods are three years.
|
|
Significant Performance-Based Component. The aggregate target award value for each Named Executive Officer in 2018 is allocated
such that 60% of the value is performance-based, in the form of pRSUs, and 40% of the value is time-based RSUs. As further described below, the weighting of our CEO’s 2019 long-term equity incentive award tied to performance was
increased from 60% to 70% and the dollar value and weighting of the time-based portion was decreased from 40% to 30%.
|
|
Balanced Mix of Performance Metrics; Substantial Relative TSR
Metric Weighting. 44% of the overall award opportunity under the 2018 program
(and 73.3% of the pRSU award component) may be earned based on two relative TSR metrics. Consistent with our investors’ strong preference for the maintenance of a risk mitigation metric, 16% of the overall award opportunity (and 26.7% of
the pRSU component) may be earned based on the three-year average of the ratio of the Company’s net debt to adjusted pro forma EBITDA.
|
|
Three-Year Vesting Period. Time-based RSUs will vest in equal installments on each of the first three anniversaries of the grant date to promote retention, generally subject to the Named Executive Officer’s continued
employment with the Company on each such date. No portion of the RSUs will be vested as of the grant date. PRSUs vest at the end of the three-year performance period.
|
|
Double-Trigger Vesting. All awards granted under the 2018 program are subject to double-trigger vesting upon the consummation of a change of
control.
|
|
Dividends Paid on pRSUs when Earned, if at All. Dividend equivalents are accrued and paid on our Named Executive Officers’ pRSUs if and to the
extent pRSUs are earned based on performance during the applicable performance period, generally subject to the Named Executive Officer’s continued employment through the end of the applicable performance period.
|
|
2019 PROXY STATEMENT
|
48
|
Below Threshold (No Payout)
|
Below - 500 basis points
|
Threshold
|
- 500 basis points
|
Target
|
Equal to Index
|
Maximum
|
+ 500 basis points
|
Below Threshold (No Payout)
|
Below - 500 basis points
|
Threshold
|
- 500 basis points
|
Target
|
Equal to Index
|
Maximum
|
+ 500 basis points
|
|
2019 PROXY STATEMENT
|
49
|
Named Executive Officer
|
Threshold pRSUs
|
Target pRSUs
|
Maximum pRSUs
|
Debra A. Cafaro
|
23,492
|
89,157
|
179,513
|
Robert F. Probst
|
10,662
|
31,987
|
57,690
|
John D. Cobb
|
10,643
|
31,930
|
57,587
|
T. Richard Riney
|
7,665
|
22,995
|
41,391
|
Peter J. Bulgarelli
|
4,516
|
13,549
|
24,390
|
Named Executive Officer
|
Time-Based RSUs
|
Debra A. Cafaro
|
59,438
|
Robert F. Probst
|
21,325
|
John D. Cobb
|
21,287
|
T. Richard Riney
|
15,330
|
Peter J. Bulgarelli
|
9,034
|
|
2019 PROXY STATEMENT
|
50
|
Named Executive Officer
|
2018 Total Award Opportunity
|
2019 Total Award Opportunity
|
||||
Threshold
|
Target
|
Maximum
|
Threshold
|
Target
|
Maximum
|
|
Debra A. Cafaro
|
$ 4,635,000
|
$ 8,305,000
|
$ 13,355,000
|
$ 4,229,550
|
$ 8,775,000
|
$ 14,978,925
|
Robert F. Probst
|
1,787,805
|
2,979,675
|
4,416,192
|
1,841,439
|
3,069,065
|
4,542,217
|
John D. Cobb
|
1,784,599
|
2,974,331
|
4,408,272
|
1,838,137
|
3,063,561
|
4,534,071
|
T. Richard Riney
|
1,285,200
|
2,142,000
|
3,170,160
|
1,298,052
|
2,163,420
|
3,201,862
|
Peter J. Bulgarelli
|
675,000
|
1,125,000
|
1,665,000
|
842,400
|
1,404,000
|
2,077,920
|
health, dental and vision insurance (of which we paid 90% of the premium in 2018);
|
|
short-term disability, long-term disability and life insurance coverage (at no cost to the employee); and
|
|
participation in a 401(k) plan (to which we made matching contributions up to 3.5% of the employee’s base salary, up to the federal limit, in 2018).
|
|
2019 PROXY STATEMENT
|
51
|
|
2019 PROXY STATEMENT
|
52
|
|
2019 PROXY STATEMENT
|
53
|
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
(1)
($)
|
Stock Awards
(2)
($)
|
Option
Awards ($)
|
Non-Equity
Incentive Plan Compensation
(3)
($)
|
All Other
Compensation
(4)
($)
|
Total
($)
|
|||||||
Debra A. Cafaro
Chairman of the Board and Chief Executive Officer
|
2018
|
$1,075,000
|
$ —
|
$ 8,211,805
|
$ —
|
$ 3,749,600
|
$ 79,797
|
$ 13,116,202
|
|||||||
2017
|
1,075,000
|
—
|
17,385,196
|
3,530,299
|
3,199,200
|
64,912
|
25,254,607
|
||||||||
2016
|
1,075,000
|
—
|
2,918,592
|
2,415,093
|
3,196,190
|
61,148
|
9,666,023
|
||||||||
Robert F. Probst
Executive Vice President and Chief Financial Officer
|
2018
|
627,300
|
—
|
2,838,860
|
—
|
1,518,850
|
10,591
|
4,995,601
|
|||||||
2017
|
615,000
|
—
|
5,647,649
|
973,955
|
1,357,613
|
10,080
|
8,604,297
|
||||||||
2016
|
592,000
|
—
|
791,466
|
654,928
|
1,289,228
|
9,369
|
3,336,991
|
||||||||
John D. Cobb
Executive Vice President and Chief Investment Officer
|
2018
|
626,175
|
—
|
2,833,802
|
—
|
1,516,126
|
14,250
|
4,990,353
|
|||||||
2017
|
605,000
|
—
|
5,502,415
|
906,278
|
1,335,538
|
10,080
|
8,359,311
|
||||||||
2016
|
541,000
|
—
|
730,522
|
604,494
|
1,216,033
|
9,369
|
3,101,418
|
||||||||
T. Richard Riney
Executive Vice President, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer
|
2018
|
571,200
|
—
|
2,040,801
|
—
|
1,338,036
|
12,397
|
3,962,434
|
|||||||
2017
|
560,000
|
—
|
4,436,973
|
890,050
|
1,221,500
|
12,222
|
7,120,745
|
||||||||
2016
|
541,000
|
—
|
699,808
|
579,090
|
1,178,163
|
9,369
|
3,007,430
|
||||||||
Peter J. Bulgarelli
Executive Vice President, Office; President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. (5)
|
2018
|
329,178
|
675,000
|
979,000
|
—
|
77,824
|
4,318
|
2,065,320
|
|||||||
(1)
|
The amount shown in the Bonus column for Mr. Bulgarelli represents the payment of his minimum guaranteed annual cash incentive for 2018 only (his target
annual cash incentive amount), pursuant to the terms of his offer of employment.
|
(2)
|
The amounts shown in the Stock Awards column for 2018 reflect the full grant
date fair value of the 2018 pRSUs and the 2018 time-based RSUs, which are calculated pursuant to FASB guidance relating to fair value provisions for share-based payments. See Note 12 of the Notes to Consolidated Financial Statements
included in the 2018 Form 10-K for a discussion of the relevant assumptions used in calculating grant date fair value. For further information on these awards, see the 2018 Grants of Plan-Based Awards Table and 2018 Outstanding Equity
Awards at Fiscal Year-End Table in this Proxy Statement. These grant date award values, including the maximum potential value of pRSUs as of the grant date, are shown below.
|
Name
|
Time-Based RSUs
|
pRSUs (at Target)
|
Total Grant Date Fair Value
|
Maximum Value of pRSUs
|
Debra A. Cafaro
|
$ 3,321,990
|
$ 4,889,815
|
$ 8,211,805
|
$ 9,845,391
|
Robert F. Probst
|
1,191,854
|
1,647,006
|
2,838,860
|
2,970,459
|
John D. Cobb
|
1,189,730
|
1,644,072
|
2,833,802
|
2,965,158
|
T. Richard Riney
|
856,794
|
1,184,007
|
2,040,801
|
2,131,219
|
Peter J. Bulgarelli
|
449,984
|
529,016
|
979,000
|
952,299
|
(3)
|
The amounts shown in the Non-Equity Incentive Plan Compensation column reflect annual
cash incentive awards earned by our Named Executive Officers for performance in 2018, 2017 and 2016. For Mr. Bulgarelli, this amount includes only the amount he earned in excess of his minimum guaranteed bonus for 2018 only.
|
(4)
|
The amounts shown in the All Other Compensation column for 2018 include supplemental
disability insurance premiums (in the amount of $57,913) and supplemental life insurance premiums paid on behalf of Ms. Cafaro; group term life insurance premiums paid on behalf of our Named Executive Officers; reimbursement for the payment
of taxes relating to such group term life insurance for Ms. Cafaro (in the amount of $2,333); our matching contributions to the Named Executive Officers’ 401(k) plan accounts (in the amount of $9,625 for each Named Executive Officer other
than Mr. Bulgarelli, who received $3,039); and, for Mr. Cobb only, an executive physical medical examination (in the amount of $3,995).
|
(5)
|
Mr. Bulgarelli commenced employment with the Company on April 9, 2018.
|
|
2019 PROXY STATEMENT
|
54
|
All Other
Stock Awards:
Number of
Shares of Stock or
Units
(#) |
Grant Date
Fair Value
of Stock
and
Option Awards(1)
($)
|
|||||||||||||||||
Name
|
Grant
Date
|
Estimated Possible Payouts Under
Non-Equity Incentive Plan Awards
|
Estimated future payouts under equity incentive plan awards
|
|||||||||||||||
Threshold
($)
|
Target
($)
|
Maximum
($)
|
Threshold
(#)
|
Target
(#)
|
Maximum
(#)
|
|||||||||||||
Debra A. Cafaro
|
—
|
(2)
|
$1,290,000
|
$2,150,000
|
$3,870,000
|
—
|
—
|
—
|
—
|
$ —
|
||||||||
1/24/2018
|
(3)
|
—
|
—
|
—
|
23,492
|
89,157
|
179,513
|
—
|
4,889,815
|
|||||||||
1/24/2018
|
(4)
|
—
|
—
|
—
|
—
|
—
|
—
|
59,438
|
3,321,990
|
|||||||||
Robert F. Probst
|
—
|
(2)
|
784,125
|
1,097,775
|
1,568,250
|
—
|
—
|
—
|
—
|
—
|
||||||||
1/24/2018
|
(3)
|
—
|
—
|
—
|
10,662
|
31,987
|
57,690
|
—
|
1,647,006
|
|||||||||
1/24/2018
|
(4)
|
—
|
—
|
—
|
—
|
—
|
—
|
21,325
|
1,191,854
|
|||||||||
John D. Cobb
|
—
|
(2)
|
782,719
|
1,095,806
|
1,565,438
|
—
|
—
|
—
|
—
|
—
|
||||||||
1/24/2018
|
(3)
|
—
|
—
|
—
|
10,643
|
31,930
|
57,587
|
—
|
1,644,072
|
|||||||||
1/24/2018
|
(4)
|
—
|
—
|
—
|
—
|
—
|
—
|
21,287
|
1,189,730
|
|||||||||
T. Richard Riney
|
—
|
(2)
|
714,000
|
999,600
|
1,428,000
|
—
|
—
|
—
|
—
|
—
|
||||||||
1/24/2018
|
(3)
|
—
|
—
|
—
|
7,665
|
22,995
|
41,391
|
—
|
1,184,007
|
|||||||||
1/24/2018
|
(4)
|
—
|
—
|
—
|
—
|
—
|
—
|
15,330
|
856,794
|
|||||||||
Peter J. Bulgarelli
|
—
|
(2)
|
450,000
|
675,000
|
900,000
|
—
|
—
|
—
|
—
|
—
|
||||||||
4/9/2018
|
(3)
|
—
|
—
|
—
|
4,516
|
13,549
|
24,390
|
—
|
529,016
|
|||||||||
4/9/2018
|
(4)
|
—
|
—
|
—
|
—
|
—
|
—
|
9,034
|
449,984
|
(1)
|
The amounts shown reflect the full grant date fair value of the awards calculated pursuant to FASB guidance regarding fair value provisions for
share-based payments. See Note 12 of the Notes to Consolidated Financial Statements included in our 2018 Form 10-K for a discussion of the relevant assumptions used in calculating grant date fair value.
|
(2)
|
The amounts shown represent each Named Executive Officer’s threshold, target and maximum annual cash incentive opportunities for performance in 2018.
These opportunities were approved by our Compensation Board Members in January 2018 (and March 2018 in the case of Mr. Bulgarelli). The actual amount of each Named Executive Officer’s award is based on the achievement of certain performance
measures as discussed in our CD&A. The annual cash incentive awards earned by our Named Executive Officers for performance in 2018 were paid during the first quarter of 2019. Such earned awards are shown in the “Non-Equity Incentive
Plan Compensation” column of the 2018 Summary Compensation Table.
|
(3)
|
The amounts shown represent our Named Executive Officer’s threshold, target and maximum pRSU award opportunities for performance from January 1, 2018 –
December 31, 2020. These opportunities were approved by our Compensation Board Members in January 2018 (and March 2018 in the case of Mr. Bulgarelli). The actual amount of each Named Executive Officer’s earned pRSUs, if any, will be based
on the achievement of certain performance measures as discussed in our CD&A.
|
(4)
|
The amounts shown reflect time-based RSUs granted to our Named Executive Officers as part of the forward-looking long-term equity incentive plan for 2018.
These shares vest in three equal annual installments, with the first installment vesting on the first anniversary of the date of grant.
|
|
2019 PROXY STATEMENT
|
55
|
|
Option Awards (1)
|
Stock Awards (1)
|
||||||||||||||
Number of
Securities
Underlying Unexercised
Options
Exercisable
(#)
|
Number of Securities Underlying Unexercised Options Unexercisable
(2)
(#)
|
Option Exercise
Price
($)
|
Option Expiration
Date
|
Number of Shares
or Units That
Have Not Vested
(3)
(#)
|
Market Value of
Shares or Units That
Have Not Vested(4)
($)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (5)
(#)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested(4)
($)
|
|||||||||
Debra A. Cafaro
|
204,248
|
—
|
$ 45.00
|
|
1/24/2021
|
|
—
|
$ —
|
—
|
$ —
|
||||||
|
216,906
|
—
|
46.88
|
|
1/18/2022
|
|
—
|
—
|
—
|
—
|
||||||
|
208,802
|
—
|
|
55.50
|
|
1/23/2023
|
|
—
|
—
|
—
|
—
|
|||||
|
421,756
|
—
|
51.85
|
|
1/29/2024
|
|
—
|
—
|
—
|
—
|
||||||
|
377,758
|
—
|
65.94
|
|
1/21/2025
|
|
—
|
—
|
—
|
—
|
||||||
|
123,870
|
—
|
53.79
|
1/27/2026
|
|
—
|
—
|
—
|
—
|
|||||||
123,870
|
—
|
65.45
|
5/4/2026
|
—
|
—
|
—
|
—
|
|||||||||
123,870
|
—
|
73.71
|
8/3/2026
|
—
|
—
|
—
|
—
|
|||||||||
123,870
|
—
|
63.24
|
11/2/2026
|
—
|
—
|
—
|
—
|
|||||||||
448,720
|
224,359
|
62.22
|
1/18/2027
|
—
|
—
|
—
|
—
|
|||||||||
|
—
|
—
|
—
|
|
—
|
|
163,987
|
9,607,998
|
344,170
|
21,493,510
|
||||||
Robert F. Probst
|
26,083
|
—
|
65.94
|
1/21/2025
|
—
|
—
|
—
|
—
|
||||||||
|
33,592
|
—
|
53.79
|
1/27/2026
|
—
|
—
|
—
|
—
|
||||||||
33,591
|
—
|
65.45
|
5/4/2026
|
—
|
—
|
—
|
—
|
|||||||||
33,591
|
—
|
73.71
|
8/3/2026
|
—
|
—
|
—
|
—
|
|||||||||
33,591
|
—
|
63.24
|
11/2/2026
|
—
|
—
|
—
|
—
|
|||||||||
123,795
|
61,897
|
62.22
|
1/18/2027
|
—
|
—
|
—
|
—
|
|||||||||
—
|
—
|
|
—
|
|
—
|
|
56,425
|
3,305,941
|
102,169
|
6,366,774
|
||||||
John D. Cobb
|
28,724
|
—
|
59.21
|
|
3/8/2023
|
|
—
|
—
|
—
|
—
|
||||||
|
26,634
|
—
|
51.85
|
|
1/29/2024
|
|
—
|
—
|
—
|
—
|
||||||
78,753
|
—
|
65.94
|
|
1/21/2025
|
|
—
|
—
|
—
|
—
|
|||||||
31,005
|
—
|
53.79
|
1/27/2026
|
—
|
—
|
—
|
—
|
|||||||||
31,005
|
—
|
65.45
|
5/4/2026
|
—
|
—
|
—
|
—
|
|||||||||
31,004
|
—
|
73.71
|
8/3/2026
|
—
|
—
|
—
|
—
|
|||||||||
31,004
|
—
|
63.24
|
11/2/2026
|
—
|
—
|
—
|
—
|
|||||||||
115,193
|
57,596
|
62.22
|
1/18/2027
|
—
|
—
|
—
|
—
|
|||||||||
|
—
|
—
|
—
|
|
—
|
|
55,661
|
3,261,178
|
101,343
|
6,314,169
|
||||||
T. Richard Riney
|
78,844
|
—
|
65.94
|
|
1/21/2025
|
|
—
|
—
|
—
|
—
|
||||||
|
29,702
|
—
|
53.79
|
1/27/2026
|
—
|
—
|
—
|
—
|
||||||||
|
29,702
|
—
|
65.45
|
5/4/2026
|
—
|
—
|
—
|
—
|
||||||||
29,701
|
—
|
73.71
|
8/3/2026
|
—
|
—
|
—
|
—
|
|||||||||
|
29,701
|
—
|
63.24
|
11/2/2026
|
—
|
—
|
—
|
—
|
||||||||
113,130
|
56,565
|
62.22
|
1/18/2027
|
—
|
—
|
—
|
—
|
|||||||||
|
—
|
—
|
—
|
|
—
|
|
42,908
|
2,513,980
|
73,792
|
4,599,289
|
||||||
Peter J. Bulgarelli
|
—
|
—
|
—
|
—
|
|
9,034
|
529,302
|
24,390
|
1,486,814
|
(1)
|
All awards are reported on a post-spin-off of Care Capital Properties, Inc. (the “Spin-off”) basis in order to reflect the arithmetic adjustment made to
outstanding awards as of August 17, 2015, the effective date of the Spin-off, in order to exclude the impact of the Spin-off. The awards granted to our current Named Executive Officers shown in these columns (awards granted as of December
31, 2018) will vest (or have vested) as follows:
|
|
2019 PROXY STATEMENT
|
56
|
|
|
Ms. Cafaro
|
Mr. Probst
|
Mr. Cobb
|
Mr. Riney
|
Mr. Bulgarelli
|
|||||
|
|
Options
|
Shares/Units
|
Options
|
Shares/Units
|
Options
|
Shares/Units
|
Options
|
Shares
|
Options
|
Shares/Units
|
2019
|
January 18
|
224,359
|
87,888
|
61,897
|
29,499
|
57,596
|
28,864
|
56,565
|
23,258
|
||
January 24
|
19,813
|
7,109
|
7,096
|
5,110
|
|||||||
April 9
|
3,012
|
||||||||||
December 31*
|
0 - 164,657
|
0 – 44,479
|
0 – 43,756
|
0 – 32,401
|
|||||||
2020
|
January 18
|
16,661
|
5,601
|
5,510
|
4,320
|
||||||
January 24
|
19,813
|
7,108
|
7,096
|
5,110
|
|||||||
April 9
|
3,011
|
||||||||||
December 31*
|
0 – 179,513
|
0 – 57,690
|
0 – 57,587
|
0 – 41,391
|
0 – 24,390
|
||||||
2021
|
January 24
|
19,812
|
7,108
|
7,095
|
5,110
|
||||||
April 9
|
3,011
|
*
|
The pRSU awards are reported on this row in a range because pRSUs may be earned, if at all, based on the Company’s performance against preestablished
performance goals from January 1, 2017 – December 31, 2019 or January 1, 2018 – December 31, 2020, as applicable. Earned awards, if any, will be paid out in the first quarter of the year following the end of the performance period.
|
(2)
|
Outstanding option awards vest in three equal annual installments beginning on the date of grant and expire on the tenth anniversary of the date of grant.
|
(3)
|
Outstanding restricted stock awards vest in three equal annual installments beginning on the date of grant and time-based RSUs vest in three equal annual
installments beginning on the first anniversary of the date of grant. The one-time transition time-based RSUs granted to certain of our Named Executive Officers vest one-third on the first anniversary of the date of grant and two-thirds on
the second anniversary of the date of grant. Our Named Executive Officers are generally entitled to dividends paid on unvested shares of restricted stock and all time-based RSUs.
|
(4)
|
For purposes of the table, the market value of restricted stock, time-based RSUs and pRSU awards that have not vested is determined by multiplying the
number of shares/units by $58.59, the closing price of our common stock on December 31, 2018.
|
(5)
|
Outstanding pRSU awards may be earned and vest, if at all, in a single installment following the end of the applicable three-year performance period the
date of grant. The pRSUs are reported at the maximum level because we are required by SEC rules to compare our performance through 2018 under the pRSU grant against the threshold, target and maximum performance levels for the grant and
report the applicable potential share number. If the performance is between levels, we are required to report the potential payout at the next highest level. For example, if performance through the previous year exceeded target, even by
only a modest amount, and even if it is unlikely that we will achieve the results that would dictate the payment of the maximum amount, we are required by SEC rules to report the maximum potential payouts. For the first year of the
2018-2020 performance period, we tracked between the target and maximum levels of performance against the three pRSU performance goals on a combined basis and have accordingly reported the pRSUs at the maximum award level. For the first two
years of the 2017-2019 performance period, we tracked between the target and maximum levels of performance against the three pRSU performance goals on a combined basis and have accordingly reported the pRSUs at the maximum award level.
Dividend equivalents are accrued and paid on our Named Executive Officers’ pRSUs if and to the extent pRSUs are earned based on performance during the
applicable performance period, generally subject to the Named Executive Officer’s continued employment through the end of the applicable performance period. Thus, the unit amounts reported in the table also include the following accrued
dividend equivalents at the maximum level (which are not paid unless and until the performance goals are met with respect to the underlying pRSUs):
|
|
2017-2019 pRSU Dividend Equivalents
|
2018-2020 pRSU Dividend Equivalents
|
Total Dividend Equivalents
|
Ms. Cafaro
|
$ 903,144
|
$ 425,446
|
$ 1,328,589
|
Mr. Probst
|
243,967
|
136,725
|
380,693
|
Mr. Cobb
|
240,002
|
136,481
|
376,483
|
Mr. Riney
|
177,719
|
98,097
|
275,816
|
Mr. Bulgarelli
|
—
|
57,804
|
57,804
|
|
2019 PROXY STATEMENT
|
57
|
|
Option Awards(1)
|
Stock Awards(1)
|
||||||
Name
|
Number of
Shares Acquired
Upon Exercise
(#)
|
Value
Realized
Upon Exercise
($)
|
Number of
Shares Acquired
Upon Vesting
(#)
|
Value
Realized
Upon Vesting(2)
($)
|
||||
Debra A. Cafaro
|
92,830
|
1,660,029
|
84,546
|
4,624,921
|
||||
Robert F. Probst
|
—
|
—
|
26,368
|
1,441,297
|
||||
John D. Cobb
|
—
|
—
|
25,356
|
1,385,695
|
||||
T. Richard Riney
|
—
|
—
|
21,701
|
1,186,648
|
||||
Peter J. Bulgarelli
|
—
|
—
|
—
|
—
|
(1)
|
If a Named Executive Officer used share withholding to pay the exercise price of options or to satisfy the tax obligations with respect to the option
exercise or the vesting of restricted stock, the number of shares acquired and the value realized were less than the amounts shown.
|
(2)
|
The amounts shown in this column reflect the value of the vested shares based on the closing price of our common stock on the vesting dates.
|
a second amended and restated employment agreement with Ms. Cafaro dated March 22, 2011 (the “Cafaro Employment Agreement”);
|
|
|
an offer letter to Mr. Probst dated September 16, 2014, and an employee protection and non-competition agreement with Mr. Probst dated September 16, 2014, as
amended (collectively, the “Probst Employee Protection Agreement”);
|
an employee protection and noncompetition agreement with Mr. Cobb dated October 21, 2013, as amended (the “Cobb Employee Protection Agreement”);
|
|
|
an amended and restated employment agreement with Mr. Riney dated July 31, 1998, as amended (the “Riney Employment Agreement”), and an amended and restated
change-in-control severance agreement with Mr. Riney dated March 22, 2011 (the “Riney Severance Agreement”); and
|
an employee protection and noncompetition agreement with Mr. Bulgarelli dated March 20, 2018 (the “Bulgarelli Employee Protection Agreement”).
|
|
2019 PROXY STATEMENT
|
58
|
Termination For Cause* or Without Good Reason*
|
• None
|
Change of Control* Without a Termination of Employment**
|
• None
|
Termination Other Than For Cause or With Good Reason
(In connection with a Change of Control or otherwise)
|
• Prorated portion of Target Bonus* for the year of termination
|
• 3x sum of (x) base salary in effect, plus (y) Target Bonus for the year of termination
|
• Full vesting of all restricted stock, stock options and other performance-related compensation (assuming maximum individual and company performance)
|
• Continuation of medical, dental, life and disability insurance benefits for two years
|
• Outplacement services, including executive office space and an executive secretary, for one year following termination, with an aggregate cost not to exceed $50,000
|
Death/Disability**
|
• Prorated portion of Target Bonus for the year of termination
|
• Continuation of medical and dental insurance benefits for two years (disability only)
|
*
|
“Cause” means Ms. Cafaro’s: (1) conviction of or plea of nolo contendere to a crime
involving moral turpitude; or (2) willful and material breach of her duties and responsibilities that is directly and materially harmful to our business and reputation and that is committed in bad faith or without reasonable belief that such
conduct is in our best interests and, with respect to (2), the Board’s adoption of a resolution by a vote of at least 75% of its members so finding after giving Ms. Cafaro and her attorney an opportunity to be heard.
|
“Change of Control” means the occurrence of any of the following events: (1) beneficial ownership by any “person” or “group” (as those terms are
defined in the Exchange Act), other than us, our subsidiaries or any employee benefit plan maintained by us, of 20% or more of any class of our outstanding equity securities or the combined voting power of our outstanding voting securities;
(2) persons who constituted our Board as of March 22, 2011, together with any new director whose election or nomination for election was approved by a vote of a majority of those persons, cease for any reason to constitute a majority of our
Board; (3) consummation of a merger, consolidation or reorganization involving us (subject to certain exceptions); (4) approval by our stockholders of a complete liquidation or dissolution of our company; (5) approval by our stockholders of
an agreement for the assignment, sale, conveyance, transfer, lease or other disposition of all or substantially all of our assets to any person, other than our subsidiaries; (6) any transaction which is reasonably likely to result in our
company ceasing to be a REIT; and (7) any other event that the Board determines constitutes an effective Change of Control.
|
|
“Good Reason” means the occurrence of any of the following events: (1) a diminution in Ms. Cafaro’s position, authority, duties or
responsibilities as Chief Executive Officer (Ms. Cafaro ceasing to be the chief executive officer of a publicly-traded company following a transaction in which we are a participant will constitute a diminution under this clause (1)); (2) a
reduction in Ms. Cafaro’s base salary, maximum annual bonus opportunity or, except as uniformly applicable to all of our similarly situated executives, benefits and perquisites; (3) our requiring Ms. Cafaro to relocate her principal business
office to a location more than 30 miles from her existing office; (4) our failure or refusal to comply with any provision of the Cafaro Employment Agreement; (5) certain events of bankruptcy involving our company; and (6) our failure to
obtain the assumption of the Cafaro Employment Agreement by any successor to all or substantially all of our business and/or assets.
|
|
“Target Bonus” means the greater of (1) the highest bonus paid to Ms. Cafaro pursuant to our annual incentive plan for any of the three
preceding calendar years and (2) the full amount of Ms. Cafaro’s annual bonus, assuming maximum individual and company performance, in respect of service for the year of termination.
|
|
**
|
Certain of Ms. Cafaro’s outstanding backward-looking stock option and restricted stock awards would have vested in full upon death, disability
or a change of control pursuant to the terms of the applicable incentive plan or award agreement. However, all forward-looking pRSU, time-based RSU and one-time transition time-based RSUs are “double-trigger” and do not vest solely upon a
change of control.
|
|
2019 PROXY STATEMENT
|
59
|
Termination For Cause* or Without Good Reason*
|
• None
|
Change of Control* Without a Termination of Employment**
|
• None
|
Termination Other Than For Cause or With Good Reason
(Not in connection with Change of Control)
|
• Lump sum payment equal to the sum of base salary as then in effect and Target Annual Bonus* (in the case of Messrs. Probst and Bulgarelli) or Maximum Annual Bonus* (in the case of Mr. Cobb) for the year of termination
|
• Continuation of medical, dental and vision insurance benefits for up to one year (or lump sum equivalent in cash)
|
Termination Other Than For Cause or With Good Reason
(Within one year of Change of Control)
|
• Lump sum payment equal to 2x (in the case of Mr. Probst) or 2.5x (in the case of Messrs. Cobb and Bulgarelli) the sum of base salary as then in effect and Maximum Annual Bonus (in the case of Mr. Probst) or Target Annual Bonus (in
the case of Messrs. Cobb and Bulgarelli) for the year of termination
|
• Continuation of medical, dental and vision insurance benefits for up to two years (or lump sum equivalent in cash)
|
Death/Disability **
|
• None
|
*
|
“Cause” means the Executive’s: (1) indictment for, conviction of, or plea of nolo
contendere to any felony or misdemeanor involving fraud, dishonesty or moral turpitude; (2) willful or intentional material breach of duties and responsibilities; (3) willful or intentional material misconduct in the performance of
duties; or (4) willful or intentional failure to comply with any lawful instruction or directive of the Chief Executive Officer.
|
“Change of Control” means the occurrence of any of the following events: (1) beneficial ownership by any “person” or “group” (as those terms are
defined in the Exchange Act), other than us, our subsidiaries or any employee benefit plan maintained by us, of 35% or more of the combined voting power of our outstanding voting securities; (2) persons who constituted our Board as of
September 30, 2013 (in the case of Messrs. Probst and Cobb) or March 20, 2018 (in the case of Mr. Bulgarelli), together with any new director whose election or nomination for election was approved by a vote of a majority of those persons,
cease for any reason to constitute a majority of our Board; (3) consummation of a merger, consolidation or reorganization involving us (subject to certain exceptions); (4) approval by our stockholders of a complete liquidation or dissolution
of our company; or (5) approval by our stockholders of an agreement for the assignment, sale, conveyance, transfer, lease or other disposition of all or substantially all of our assets to any person, other than our subsidiaries.
|
|
“Good Reason” means the occurrence of any of the following events: (1) a material diminution of the Executive’s position, authority or duties;
(2) a material reduction in the Executive’s base salary or Target Annual Bonus opportunity; (3) our requiring the Executive to relocate his principal business office to any location that is more than 30 miles from our current Chicago
headquarters; or (4) our failure to cause the assumption of the Employee Protection Agreement by any successor to all or substantially all of our business and/or assets, in each case, that is not cured within 30 days after written notice from
the Executive.
|
|
“Maximum Annual Bonus” means the full amount of the Executive’s annual bonus, assuming maximum individual and company performance.
|
|
“Target Annual Bonus” means the Executive’s annual bonus, assuming target individual and company performance.
|
|
**
|
Certain of the Executives’ outstanding backward-looking stock option and restricted stock awards would have vested in full upon death,
disability or a change of control pursuant to the terms of the applicable incentive plan or award agreement. However, all forward-looking pRSU, time-based RSU and one-time transition time-based RSUs are “double-trigger” and do not vest solely
upon a change of control.
|
|
2019 PROXY STATEMENT
|
60
|
Termination For Cause* or Without Good Reason*
|
• None
|
Change of Control* Without a Termination of Employment**
|
• Payment for any excise taxes he may incur as a result of the Change of Control
|
Termination Other Than For Cause or With Good Reason
(Not in connection with Change of Control)
|
• Lump sum payment (not to exceed $3 million, as adjusted annually beginning in 2008 to reflect increases in the Consumer Price Index (“CPI”)) equal to (x) prorated portion of Target Bonus* for the year of termination, plus (y) the sum
of base salary as then in effect and Target Bonus for the year of termination
|
• Credited with one additional year of service for purposes of vesting of restricted stock
|
• Continuation of medical, dental, life and long-term disability insurance benefits for up to one year
|
Termination Other Than For Cause or With Good Reason
(Within two years of Change of Control)
|
• Lump sum payment (not to exceed $3 million, as adjusted annually beginning in 2008 to reflect increases in CPI) equal to 2x the greater of (a) the sum of (x) base salary and Target Bonus as of the date of termination, plus (y) the
fair market value of the maximum number of shares of restricted stock authorized to be issued to Mr. Riney for the year of termination, and (b) the sum of (x) base salary and Target Bonus as of the date immediately prior to the
effectiveness of the Change of Control, plus (y) the fair market value of the maximum number of shares of restricted stock authorized to be issued to him for the year in which the date immediately prior to the effectiveness of the Change
of Control occurs
|
• Continuation of medical, dental, life and disability insurance benefits for two years
|
• Payment for any excise taxes he may incur as a result of the Change of Control
|
Death/Disability**
|
• Prorated portion of Target Bonus for the year of termination
|
*
|
“Cause” means Mr. Riney's: (1) conviction of or plea of nolo contendere to a crime
involving moral turpitude; or (2) willful and material breach of his duties and responsibilities that is committed in bad faith or without reasonable belief that such conduct is in our best interests and, with respect to (2), the Board’s
adoption of a resolution by a vote of at least 75% of its members so finding after giving Mr. Riney and his attorney an opportunity to be heard.
|
“Good Reason” means the occurrence of any of the following events: (1) the assignment to Mr. Riney of duties substantially of a non-executive or
non-managerial nature; (2) an adverse change in Mr. Riney’s status or position as an executive officer, including as a result of a diminution in his duties and responsibilities (other than a change directly attributable to our ceasing to be a
publicly owned company); (3) a reduction in Mr. Riney’s base salary, bonus opportunity or, except as uniformly applicable to all of our similarly situated executives, benefits and perquisites (which reduction, for purposes of the Riney
Employment Agreement, is material); (4) our requiring Mr. Riney to relocate his principal business office to a location more than 30 miles from his existing office; and (5) our failure to obtain the assumption of the Riney Employment
Agreement by any successor to all or substantially all of our business or assets, in each case, for purposes of the Riney Employment Agreement, that is not cured within 30 days after written notice from Mr. Riney.
|
|
“Change of Control” means the occurrence of any of the following events: (1) beneficial ownership by any “person” or “group” (as those terms are
defined in the Exchange Act), other than us, our subsidiaries or any employee benefit plan maintained by us, of 20% or more of the combined voting power of our outstanding voting securities; (2) persons who constituted our Board as of May 1,
1998, together with any new director whose election or nomination for election was approved by a vote of a majority of those persons, cease for any reason to constitute a majority of our Board; (3) consummation of a merger, consolidation or
reorganization involving us (subject to certain exceptions); (4) approval by our stockholders of a complete liquidation or dissolution of our company; (5) approval by our stockholders of an agreement for the assignment, sale, conveyance,
transfer, lease or other disposition of all or substantially all of our assets to any person, other than our subsidiaries; and (6) any other event that the Board determines constitutes an effective Change of Control.
|
|
2019 PROXY STATEMENT
|
61
|
“Target Bonus” means the full amount of bonuses and performance compensation that would be payable to Mr. Riney, assuming satisfaction of all
performance criteria on which such bonuses and performance compensation are based, in respect of services for the year of termination.
|
|
**
|
Certain of Mr. Riney's outstanding backward-looking stock option and restricted stock awards would have vested in full upon death, disability or
a change of control pursuant to the terms of the applicable incentive plan or award agreement. However, all forward-looking pRSU, time-based RSU and one-time transition time-based RSUs are “double-trigger” and do not vest solely upon a change
of control.
|
|
✓ |
termination for Cause or without Good Reason;
|
✓ |
termination other than for Cause or with Good Reason (“involuntary termination”);
|
✓ |
a Change of Control (without any termination of employment);
|
✓
|
involuntary termination following a Change of Control; and
|
✓ |
death or disability.
|
Benefit
|
Termination for Cause or without Good Reason
|
Involuntary Termination (without Change of Control)
|
Change of Control (without Termination)
|
Involuntary Termination Following Change of Control(1)
|
Death or Disability
|
|||||
Debra A. Cafaro
|
|
|
|
|
|
|||||
Prorated portion of Target Bonus for year of termination(2)
|
$ —
|
$ 3,870,000
|
$ —
|
$ 3,870,000
|
$ 3,870,000
|
|||||
Payment equal to multiple of base salary in effect at termination(3)
|
—
|
3,225,000
|
—
|
3,225,000
|
—
|
|||||
Payment equal to multiple of Target Bonus for year of termination(2)(3)
|
—
|
11,610,000
|
—
|
11,610,000
|
—
|
|||||
Vesting of equity awards(4)(5)
|
—
|
31,101,508
|
1,662,140
|
31,101,508
|
19,847,032
|
|||||
Continued insurance benefits(6)
|
—
|
233,514
|
—
|
233,514
|
52,843
|
|||||
Office space and administrative services
|
—
|
50,000
|
—
|
50,000
|
—
|
|||||
Reduction(7)
|
—
|
—
|
—
|
—
|
—
|
|||||
Total for Debra A. Cafaro
|
$ —
|
$ 50,090,023
|
$ 1,662,140
|
$ 50,090,023
|
$ 23,769,876
|
|||||
Robert F. Probst
|
||||||||||
Payment equal to multiple of base salary in effect at termination(3)
|
—
|
627,300
|
—
|
1,254,600
|
—
|
|||||
Payment equal to multiple of Target Annual Bonus for year of termination(2)(3)
|
—
|
1,097,775
|
|
—
|
—
|
—
|
||||
Payment equal to multiple of Maximum Annual Bonus for year of termination(2)(3)
|
—
|
—
|
—
|
3,136,500
|
—
|
|||||
Vesting of equity awards(4)(5)
|
—
|
3,340,581
|
458,525
|
6,839,162
|
6,839,162
|
|||||
Continued insurance benefits(6)
|
—
|
26,569
|
—
|
53,138
|
—
|
|||||
Reduction(7)
|
—
|
—
|
—
|
(2,233,425)
|
—
|
|||||
Total for Robert F. Probst
|
$ —
|
$ 5,092,225
|
$ 458,525
|
$ 9,049,974
|
$ 6,839,162
|
|
2019 PROXY STATEMENT
|
62
|
Benefit
|
Termination for Cause or without Good Reason
|
Involuntary Termination (without Change of Control)
|
Change of Control (without Termination)
|
Involuntary Termination Following Change of Control(1)
|
Death or Disability
|
|||||
John D. Cobb
|
|
|
|
|
|
|||||
Payment equal to multiple of base salary in effect at termination(3)
|
—
|
$ 626,175
|
—
|
$ 1,565,438
|
—
|
|||||
Payment equal to multiple of Target Annual Bonus for year of termination(2)(3)
|
—
|
—
|
|
—
|
2,739,516
|
—
|
||||
Payment equal to multiple of Maximum Annual Bonus for year of termination(2)(3)
|
—
|
1,565,438
|
—
|
—
|
—
|
|||||
Vesting of equity awards(4)(5)
|
—
|
3,314,570
|
426,652
|
6,765,166
|
6,765,166
|
|||||
Continued insurance benefits(6)
|
—
|
26,569
|
—
|
53,138
|
—
|
|||||
Reduction(7)
|
—
|
—
|
—
|
—
|
—
|
|||||
Total for John D. Cobb
|
$ —
|
$ 5,532,752
|
$ 426,652
|
$ 11,123,257
|
$ 6,765,166
|
|||||
T. Richard Riney
|
|
|
|
|
|
|||||
Prorated portion of Target Bonus for year of termination(2)(8)
|
—
|
1,428,000
|
—
|
—
|
1,428,000
|
|||||
Payment equal to multiple of base salary in effect at termination(3)(8)
|
—
|
571,200
|
—
|
1,142,400
|
—
|
|||||
Payment equal to multiple of Target Bonus for year of termination(2)(3)(8)(9)
|
—
|
1,428,000
|
—
|
2,522,476
|
—
|
|||||
Payment equal to multiple of fair market value of maximum restricted stock/RSU grant under LTIP for the year of termination(3)(8)(10)(11)
|
—
|
—
|
—
|
0
|
—
|
|||||
Vesting of equity awards(4)(5)
|
—
|
2,847,842
|
419,036
|
5,069,105
|
5,069,105
|
|||||
Continued insurance benefits(6)
|
—
|
28,735
|
—
|
57,470
|
—
|
|||||
Excise tax gross-up(5)
|
—
|
—
|
—
|
—
|
—
|
|||||
Total for T. Richard Riney
|
$ —
|
$ 6,303,777
|
$ 419,036
|
$ 8,791,451
|
$ 6,497,105
|
|||||
Peter J. Bulgarelli
|
|
|
|
|
|
|||||
Payment equal to multiple of base salary in effect at termination(3)
|
—
|
450,000
|
—
|
1,125,000
|
—
|
|||||
Payment equal to multiple of Target Annual Bonus for year of termination(2)(3)
|
—
|
675,000
|
|
—
|
1,687,500
|
—
|
||||
Vesting of equity awards(4)(5)
|
—
|
653,241
|
—
|
1,355,249
|
1,355,249
|
|||||
Continued insurance benefits(6)
|
—
|
26,569
|
—
|
53,138
|
—
|
|||||
Reduction(7)
|
—
|
—
|
—
|
—
|
—
|
|||||
Total for Peter J. Bulgarelli
|
$ —
|
$ 1,804,810
|
$ —
|
$ 4,220,887
|
$ 1,355,249
|
(1)
|
Involuntary termination during any time following Change of Control for Ms. Cafaro (the occurrence of a Change of Control does not result in enhanced severance benefits for
Ms. Cafaro), involuntary termination within one year of Change of Control for Messrs. Probst, Cobb and Bulgarelli and involuntary termination within two years of Change of Control for Mr. Riney.
|
(2)
|
“Target Bonus,” “Target Annual Bonus” or “Maximum Annual Bonus,” as applicable, for each Named Executive Officer is defined above under “Employment and Severance Agreements
with Named Executive Officers.”
|
(3)
|
Multiples for the Named Executive Officers are as follows:
|
|
Involuntary Termination
(without Change of Control)
|
Involuntary Termination
Following Change of Control
|
Ms. Cafaro
|
3x
|
3x
|
Messrs. Probst and Riney
|
1x
|
2x
|
Messrs. Cobb and Bulgarelli
|
1x
|
2.5x
|
|
2019 PROXY STATEMENT
|
63
|
(4)
|
The outstanding restricted stock and stock option award agreements under our 2012 Incentive Plan generally provide that, upon a Change of Control or in the
event of death, disability or retirement of a participant while employed by us, the stock options underlying the award become immediately exercisable or the restrictions and other conditions pertaining to the shares of restricted stock
underlying the award immediately lapse. In the event of involuntary termination, Ms. Cafaro’s restricted stock and stock options would become fully vested and Mr. Riney would be treated as having one additional year of service for purposes of
restricted stock vesting.
The outstanding time-based RSU award agreements under our 2012 Incentive Plan (including our one-time transition RSU awards) generally provide that, upon a
Qualifying Termination (defined as an involuntary termination within 6 months prior to or 24 months following a Change of Control) or in the event of death, disability or retirement of a participant while employed by us, the restrictions and
other conditions pertaining to the RSUs immediately lapse. In the event of involuntary termination in the absence of a Change of Control, Ms. Cafaro’s time-based RSUs would become fully vested and the other Named Executive Officers would be
treated as having one additional year of service for purposes of regular (but not one-time transition) time-based RSU vesting. RSU awards do not receive any enhanced vesting solely upon a Change of Control.
The outstanding pRSU award agreements under our 2012 Incentive Plan generally provide that, upon a Qualifying Termination (defined as an involuntary
termination within 6 months prior to or 24 months following a Change of Control), Ms. Cafaro would receive full vesting of the pRSUs at the maximum level and the other Named Executive Officers would receive full vesting of the pRSUs at the
higher of actual or target performance through the change of control date (table reflects target values).
In the event of death or disability, Ms. Cafaro would receive full vesting of the pRSUs at the higher of actual or target performance through the
termination date (table reflects target value) and the other Named Executive Officers would receive full vesting of the pRSUs at the target level.
In the event of retirement while employed by us, Ms. Cafaro would receive full vesting of the pRSUs at the higher of actual or target performance through
the retirement date (table reflects target value) unless the retirement occurs after a Change of Control has occurred, in which case Ms. Cafaro would receive full vesting of the pRSUs at the maximum level. The other Named Executive Officers
would receive prorated vesting of the pRSUs at the higher of actual or target performance through the retirement date (table reflects target values).
In the event of involuntary termination in the absence of a Change of Control, Ms. Cafaro would receive full vesting of the pRSUs at the maximum level and
the other Named Executive Officers would receive prorated vesting of the pRSUs at the higher of actual or target performance through the termination date (table reflects target values).
In the event of a Change of Control in the absence of a Qualifying Termination (or subsequent retirement in the case of Ms. Cafaro only), the pRSU awards
convert to time-based awards upon a Change of Control and remain subject to the remaining vesting schedule. Ms. Cafaro’s pRSU awards convert at a level equal to the higher of actual and target performance and the other Named Executive
Officers’ pRSU awards convert at a level equal to actual performance through the Change of Control date. Accordingly, we have not reported any pRSU award values in the “Change of Control (without Termination)” column.
All pRSU award figures include the value of accrued dividend equivalents as of December 31, 2018.
Since none of our Named Executive Officers were retirement-eligible as of December 31, 2018, we have not included a “Retirement” column in the table above.
|
(5)
|
Assumes a stock price of $58.59, the closing price of our common stock on December 31, 2018. For purposes of the table, the value of vesting of restricted stock, RSUs and
pRSUs is determined by multiplying the number of shares/units vesting by $58.59, and the value of vesting of in-the-money stock options is determined by subtracting the stock option exercise price from $58.59 and multiplying by the number of
options vesting.
|
(6)
|
In the event of her Disability, Ms. Cafaro would receive continued medical and dental premiums for a period of 24 months. In the event of her involuntary termination
without Cause or for Good Reason, Ms. Cafaro would receive continued health, dental, life, short-term disability and long-term disability insurance premiums for a period of 24 months. In the event of involuntary termination without Cause or
for Good Reason for each of Messrs. Probst, Cobb or Bulgarelli, such individual would receive continued health, dental and vision insurance premiums for a period of 12 months (24 months if such termination occurs within one year of a Change
of Control). In the event of his involuntary termination without Cause or for Good Reason, Mr. Riney would receive continued health, dental, life, short-term disability and long-term disability insurance premiums for a period of 12 months (24
months if such termination occurs within two years of a Change of Control).
|
(7)
|
Pursuant to the Cafaro Employment Agreement and the Employee Protection Agreements for the Executives, under certain circumstances, payments or benefits to Ms. Cafaro and
Messrs. Probst, Cobb and Bulgarelli are subject to reduction such that there will be no taxes imposed upon them by Section 4999 of the Code or any similar state or local tax. The reduction amount in the table above is based on a number of
assumptions (including no value being assigned to restrictive covenants such as noncompetition and nonsolicitation provisions), which may ultimately be different at the time of a Change of Control or Qualifying Termination, resulting in
corresponding adjustments to the reduction amount.
|
(8)
|
Under the Riney Employment Agreement and the Riney Severance Agreement, the amount of certain severance benefits payable to Mr. Riney is limited to a maximum of $3 million,
as adjusted annually following the effective date of the applicable agreement to reflect increases in CPI.
|
(9)
|
This amount has been reduced from $2,856,000 to $2,522,476 because the total severance due to Mr. Riney under this termination scenario would exceed $3,664,876, which is
equal to Mr. Riney’s $3 million severance cap after adjusting for 2007-2017 CPI based on an assumed December 31, 2018 termination date.
|
(10)
|
The fair market value of the maximum restricted stock/RSU grant under the long-term equity incentive plan is determined by multiplying the sum of restricted shares, RSUs
and pRSUs (deemed earned at the maximum level) granted in 2018 by the closing price of our shares on the assumed change in control date of December 31, 2018.
|
(11)
|
This amount has been reduced from $6,646,567 to $0 because the total severance due to Mr. Riney under this termination scenario would exceed $3,664,876, which is equal to
Mr. Riney’s $3 million severance cap after adjusting for 2007-2017 CPI based on an assumed December 31, 2018 termination date.
|
|
2019 PROXY STATEMENT
|
64
|
|
2019 PROXY STATEMENT
|
65
|
Board retainer: Each non-employee director received a retainer of $105,000 for each calendar year in which he or she served as a director. The Presiding Director received an
additional retainer of $25,000 for each calendar year of service.
|
Committee retainers: Each member (other than the chair) of the Audit, Compensation and Nominating Committees received a retainer of $20,000, $20,000 and $15,000,
respectively, for each calendar year of service as a member of such committee. The chair of the Audit, Compensation and Nominating Committees received a retainer of $25,000, $25,000 and $20,000, respectively, for each calendar year of service
as the chair of that committee.
|
Board and committee meeting fees: Each non-employee director received $1,500 for each Board meeting he or she attended in excess of the eighth Board meeting held during the
year, $1,500 for each Audit, Compensation or Nominating Committee meeting he or she attended in excess of the sixth such committee meeting held during the year and $1,500 for each Investment or Executive Committee meeting he or she attended
during the year (in each case, including telephonic meetings, unless the meeting was 30 minutes or less).
|
Each year, our non-employee directors receive shares of restricted stock or restricted stock units, at his or her prior election, having an aggregate value equal to
$165,000.
|
Upon initial election or appointment to the Board, a newly-elected or appointed non-employee director would have received a number of shares of restricted stock having an
aggregate value equal to a pro rata portion of $165,000 (determined by reference to the number of days remaining in the annual grant cycle).
|
|
2019 PROXY STATEMENT
|
66
|
|
2019 PROXY STATEMENT
|
67
|
Name
|
Fees Earned or Paid in
Cash(1)
($)
|
Stock Awards(2)
($)
|
Total
($)
|
|||
Melody C. Barnes
|
128,832
|
164,985
|
293,817
|
|||
Jay M. Gellert
|
126,187
|
164,985
|
291,172
|
|||
Richard I. Gilchrist
|
134,896
|
164,985
|
299,881
|
|||
Matthew J. Lustig
|
104,250
|
164,985
|
269,235
|
|||
Roxanne M. Martino
|
124,250
|
164,985
|
289,235
|
|||
Walter C. Rakowich
|
121,250
|
164,985
|
286,235
|
|||
Robert D. Reed
|
126,250
|
164,985
|
291,235
|
|||
Glenn J. Rufrano (3)
|
42,953
|
—
|
42,953
|
|||
James D. Shelton
|
166,250
|
164,985
|
331,235
|
(1)
|
The amounts shown in the Fees Earned or Paid in Cash column reflect quarterly retainer and meeting fees
described above under “—Cash Compensation.” Of the amounts shown in this column, the following directors elected to defer all or a portion of their retainer and meeting fees pursuant to the Director Deferred Compensation Plan described above
and were credited with the following stock units: Mr. Gellert, $126,187 or 2,305 units; Mr. Lustig, $104,250 or 1,905 units; Ms. Martino, $124,250 or 2,270 units; Mr. Reed, $126,250 or 2,308 units; Mr. Rufrano, $42,953 or 770 units; and
Mr. Shelton, $83,125 or 1,519 units.
|
(2)
|
The amounts shown in the Stock Awards column represent the full grant date fair value of shares
of restricted stock or restricted stock units (excluding stock units credited in lieu of retainer and meeting fees) granted to each non-employee director in 2018, calculated pursuant to FASB guidance regarding fair value provisions for
share-based awards. See Note 12 of the Notes to Consolidated Financial Statements included in our 2018 Form 10-K for a discussion of the relevant assumptions used in calculating grant date fair value. Directors are generally entitled to
dividends paid on unvested shares of restricted stock and dividend equivalents on vested and unvested restricted stock units.
As of December 31, 2018, the aggregate number of unvested shares of restricted stock and restricted stock units and the aggregate number of shares
underlying unexercised stock options (all of which are vested) held by each non-employee director were as follows (shown on a post-Spin-off basis):
|
|
Unvested Shares of Restricted Stock and Restricted Stock Units
|
Shares Underlying Unexercised Vested Stock Options
|
Ms. Barnes
|
4,719 shares
|
0 shares
|
Mr. Gellert
|
4,719 shares
|
17,820 shares
|
Mr. Gilchrist
|
4,719 shares
|
8,934 shares
|
Mr. Lustig
|
4,719 shares
|
9,731 shares
|
Ms. Martino
|
4,719 shares
|
0 shares
|
Mr. Rakowich
|
4,719 shares
|
0 shares
|
Mr. Reed
|
4,719 shares
|
17,820 shares
|
Mr. Rufrano
|
0 shares
|
15,265 shares
|
Mr. Shelton
|
4,719 shares
|
17,820 shares
|
(3)
|
Mr. Rufrano did not stand for reelection to the Board at the 2018 Annual Meeting of Directors and therefore terminated his service with the Board effective as of May 14,
2018.
|
|
2019 PROXY STATEMENT
|
68
|
Plan Category
|
(a)
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
|
(b)
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
|
(c)
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in
Column (a))
|
|||
Equity compensation plans approved by stockholders(1)
|
4,784,333
|
$ 59.20
|
6,592,721
|
|||
Equity compensation plans not approved by stockholders(2)
|
83,977
|
N/A
|
1,032,282
|
|||
Total
|
4,868,310
|
$ 59.20
|
7,625,003
|
(1)
|
These plans consist of: (a) the Employee and Director Stock Purchase Plan; (b) the 2006 Incentive Plan; (c) the 2006 Stock Plan for Directors; (d) and the 2012 Incentive
Plan. As of December 31, 2018, 2,847,426 shares were available for future issuance under the Employee and Director Stock Purchase Plan and 3,745,295 shares were available for grant under the 2012 Incentive Plan. No additional grants are
permitted under the Nationwide Health Properties, Inc. 2005 Performance Incentive Plan, the 2006 Incentive Plan or the 2006 Stock Plan for Directors.
|
(2) | These plans consist of: (a) the Director Deferred Compensation Plan, under which our non-employee directors may receive, in lieu of director fees, units that settle into shares of our common stock on a one-for-one basis; and (b) the Executive Deferred Stock Compensation Plan, under which our executive officers may receive, in lieu of compensation, units that settle into shares of our common stock on a one-for-one basis. |
|
2019 PROXY STATEMENT
|
69
|
Name of Beneficial Owner
|
Vested and Unvested Shares of Common Stock
|
|
|
Shares Subject to Options Exercisable within 60 days
|
|
|
Stock Units That May Be Settled within 60 days
|
|
Total Shares of Common Stock Beneficially Owned
|
|
Percent of Class
|
|||||
Melody C. Barnes
|
7,824
|
+
|
—
|
+
|
—
|
=
|
|
7,824
|
*
|
|||||||
Peter J. Bulgarelli
|
—
|
|
+
|
—
|
|
+
|
3,012
|
=
|
|
3,012
|
|
*
|
||||
Debra A. Cafaro
|
645,171
|
(1)
|
+
|
2,529,945
|
+
|
—
|
=
|
|
3,175,116
|
(1)
|
*
|
|||||
John D. Cobb
|
50,686
|
|
+
|
430,918
|
|
+
|
—
|
=
|
|
481,604
|
|
*
|
||||
Jay M. Gellert
|
75,894
|
|
+
|
17,820
|
|
+
|
67,646
|
=
|
|
161,360
|
|
*
|
||||
Richard I. Gilchrist
|
27,090
|
|
+
|
8,934
|
|
+
|
—
|
=
|
|
36,024
|
|
*
|
||||
Matthew J. Lustig
|
2,656
|
|
+
|
9,731
|
|
+
|
29,828
|
=
|
|
42,215
|
|
*
|
||||
Roxanne M. Martino
|
7,541
|
|
+
|
—
|
|
+
|
5,758
|
=
|
|
13,299
|
|
*
|
||||
Robert F. Probst
|
40,991
|
|
+
|
346,140
|
|
+
|
—
|
=
|
|
387,131
|
|
*
|
||||
Walter C. Rakowich
|
7,541
|
|
+
|
—
|
|
+
|
—
|
=
|
|
7,541
|
|
*
|
||||
Robert D. Reed
|
14,913
|
|
+
|
17,820
|
|
+
|
25,278
|
=
|
|
58,011
|
|
*
|
||||
T. Richard Riney
|
176,972
|
(2)
|
+
|
367,345
|
|
+
|
—
|
=
|
|
544,317
|
(2)
|
*
|
||||
James D. Shelton
|
12,340
|
|
+
|
17,820
|
|
+
|
27,002
|
=
|
|
57,162
|
|
*
|
||||
All directors, director-nominees and executive officers as a group (13 persons)
|
1,069,619
|
|
+
|
3,746,473
|
|
+
|
161,215
|
=
|
|
4,974,616
|
|
1.4
|
%
|
*
|
Less than 1%
|
(1)
|
Includes 5,000 shares held in trust for the benefit of Ms. Cafaro’s immediate family, as to which Ms. Cafaro’s spouse is the trustee. Ms. Cafaro disclaims beneficial ownership of these 5,000
shares.
|
(2)
|
Includes 1,300 shares held in Mr. Riney’s IRA and 70,000 shares held in trust for the benefit of Mr. Riney’s spouse, as to which Mr. Riney’s spouse is the trustee.
|
|
2019 PROXY STATEMENT
|
70
|
Name and Address of Beneficial Owner
|
Common Stock
Beneficially Owned
|
Percent of
Class(1)
|
||
BlackRock, Inc.
55 East 52nd Street
New York, NY 10055
|
36,732,621
|
(2)
|
10.3
|
%
|
State Street Corporation
One Lincoln Street
Boston, MA 02111
|
21,005,400
|
(3)
|
5.9
|
%
|
The Vanguard Group
100 Vanguard Boulevard
Malvern, PA 19355
|
45,528,313
|
(4)
|
12.8
|
%
|
Vanguard Specialized Funds—Vanguard Real Estate Index Fund
100 Vanguard Boulevard
Malvern, PA 19355
|
16,969,012
|
(5)
|
4.8
|
%
|
(1)
|
Percentages are based on 357,353,468 shares of our common stock outstanding on March 15, 2019.
|
(2)
|
Based solely on information contained in a Schedule 13G/A filed by BlackRock, Inc., for itself and for certain of its affiliates (collectively, “BlackRock”), on January 31, 2019. BlackRock
reported that, as of December 31, 2018, it had sole voting power over 33,594,701 shares of our common stock and sole dispositive power over 36,732,621 shares of our common stock. BlackRock, Inc. is a parent holding company.
|
(3)
|
Based solely on information contained in a Schedule 13G filed by State Street Corp., for itself and on behalf of its subsidiaries (collectively, “State Street”), on February 14, 2019. State
Street reported that, as of December 31, 2018, it had sole voting and dispositive power over 0 shares of our common stock, shared voting power over 19,009,644 shares of our common stock and shared dispositive power over 21,000,958 shares of
our common stock.
|
(4)
|
Based solely on information contained in a Schedule 13G/A filed by The Vanguard Group, Inc. (“Vanguard”) on February 11, 2019. Vanguard reported that, as of December 31, 2018, it had sole voting
power over 730,470 shares of our common stock, shared voting power over 478,248 shares of our common stock, sole dispositive power over 44,647,893 shares of our common stock and shared dispositive power over 880,420 shares of our common
stock. Vanguard is an investment advisor registered under Section 203 of the Investment Advisers Act. Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of Vanguard, is the beneficial owner of 303,277 shares of our common stock as a
result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of Vanguard, is the beneficial owner of 1,004,336 shares of our common stock as a result of its serving
as investment manager of Australian investment offerings.
|
(5)
|
Based solely on information contained in a Schedule 13G/A filed by Vanguard Specialized Funds—Vanguard Real Estate Index Fund (“Vanguard Real Estate Fund”) on January 31, 2019. Vanguard Real
Estate Fund reported that, as of December 31, 2018, it had sole voting power over 16,969,012 shares of our common stock.
|
|
2019 PROXY STATEMENT
|
71
|
|
2016
|
2017
|
2018
|
2019
|
Average Director Tenure (Years)
|
7.8
|
7.5
|
8.6
|
9.6
|
Average Non-Employee Director Tenure (Years)
|
7.4
|
6.8
|
7.8
|
8.8
|
|
2019 PROXY STATEMENT
|
72
|
|
2019 PROXY STATEMENT
|
73
|
|
2019 PROXY STATEMENT
|
74
|
|
2019 PROXY STATEMENT
|
75
|
|
2019 PROXY STATEMENT
|
76
|
|
2019 PROXY STATEMENT
|
77
|
|
2019 PROXY STATEMENT
|
78
|
|
2019 PROXY STATEMENT
|
79
|
|
2019 PROXY STATEMENT
|
80
|
|
2018
|
2017
|
||||
Audit Fees (1)
|
$
|
3,990,000
|
$
|
3,885,000
|
||
Audit-Related Fees
|
—
|
—
|
||||
Tax Fees
|
—
|
—
|
||||
All Other Fees (2)
|
3,000
|
2,500
|
||||
Total
|
$
|
3,993,000
|
$
|
3,887,500
|
(1)
|
Audit Fees include the aggregate fees billed for professional services rendered by KPMG for the audit of our annual consolidated and entity level financial statements
(including debt covenant compliance letters), audit of internal control over financial reporting, review of interim financial statements included in our Quarterly Reports on Form 10-Q, advice on audit and accounting matters that arose
during, or as a result of, the audit or the review of interim financial statements, and work on securities offerings and other filings with the SEC, including comfort letters, consents and comment letters.
|
(2)
|
All Other Fees relate to annual subscription fees for KPMG’s online technical research site.
|
|
2019 PROXY STATEMENT
|
81
|
attracting, retaining and motivating talented executives;
|
|
rewarding performance that meets or exceeds pre-established company and tailored individual goals consistent with our strategic plan, while maintaining alignment with stockholders;
|
|
providing balanced incentives that discourage excessive risk-taking;
|
|
retaining sufficient flexibility to permit our executive officers to manage risk and adjust appropriately to meet rapidly changing market and business conditions;
|
|
evaluating performance by balancing consideration of measures over which management has significant direct influence with market forces that management cannot control (such as monetary policy
and interest rate expectations), but that impact stockholder value;
|
|
encouraging executives to become and remain long-term stockholders of our company; and
|
|
maintaining compensation and corporate governance practices that support our goal to deliver sustained, superior returns to stockholders.
|
We generally targeted approximately the median of the Comparable Companies on an overall, total direct compensation basis, subject to adjustment based on the unique skills, expertise and
individual contributions of each Named Executive Officer. Our 2018 executive compensation program was designed to deliver compensation levels above or below these targets if performance exceeded or fell below the goals established under our
annual cash and long-term equity incentive plans.
|
|
A significant portion of our executive compensation is performance-based cash and long-term equity incentive compensation. Our annual cash and long-term equity incentive awards are only earned
if our Named Executive Officers achieve certain threshold performance levels with respect to various measures that support long-term stockholder value, including three-year relative TSR metrics.
|
|
Our annual cash incentive awards may be paid, if at all, only after the requisite performance level has been achieved. Long-term equity incentive awards may be earned, if at all, based on
future three-year performance in relation to the performance goals set at the beginning of the performance period.
|
|
We support pay-for-performance by targeting a mix of executive compensation that emphasizes equity incentive awards that may be earned and vest based on long-term performance, with less weight
on fixed annual cash compensation. The use of equity awards encourages management to create long-term stockholder value because the award value is directly attributable to changes in the price of our common stock over time. Equity awards
are also an effective tool for management retention because vesting of the awards generally requires continued employment over multiple years.
|
|
Our Compensation Committee annually reviews the compensation practices and programs of our compensation peer group (generally selected based on their similarity to us in terms of operations,
FFO, enterprise value, market capitalization and total assets) and receives guidance from its independent compensation consultant on compensation best practices.
|
|
2019 PROXY STATEMENT
|
82
|
Our share ownership guidelines require our executive officers and directors to maintain significant ownership of our common stock to further align interests with our stockholders. Our
Securities Trading Policy prohibits our directors, executive officers and employees from engaging in derivative and other hedging transactions in our securities and restricts our executive officers and directors from holding our securities
in margin accounts or otherwise pledging our securities to secure loans without the approval of our Audit Committee (no executive officer or director pledged or held our securities in margin accounts at any time during 2018).
|
Our 3.4% TSR in 2018 outperformed the S&P 500 Index and the MSCI REIT Index by nearly eight percentage points. Our TSR also outperformed the MSCI REIT Index and the FTSE NAREIT Equity
Health Care Index for the three-, five- and 10-year periods ended December 31, 2018, demonstrating short- and long-term outperformance during varied economic cycles.
|
|
For the period from January 1, 2000 through December 31, 2018 (the 19 full fiscal years of our Chief Executive Officer’s tenure), we delivered compound annual TSR of 23%, dramatically
outperforming our peers, the S&P 500 Index and the MSCI REIT Index.
|
|
We increased our dividend in 2018, marking our 9th consecutive year of dividend growth.
|
Normalized FFO and Same-Store Cash NOI Growth:
|
|
Our high quality and diverse portfolio of assets delivered normalized FFO of $4.07 and same-store cash NOI growth of 1.2%;
|
|
Effective Balance Sheet Management and Efficient Capital Markets Execution:
|
|
Further strengthened our financial condition by refinancing or repaying $3.5 billion of debt, thereby extending our debt maturity profile by 0.7x to 7.0 years and minimizing
intermediate-term interest rate exposure, including the renewal and extension of our $900 million term loan at improved pricing, proactive issuance of $1.4 billion in new 10-year senior notes at attractive pricing and effective execution
and maintenance of our BBB+ credit rating and strong balance sheet with a 5.6x net debt to adjusted pro forma EBITDA ratio and a fixed charge coverage ratio of 4.6x;
|
|
Profitable Dispositions:
|
|
Continued our strategic and highly profitable disposition program, harvesting $1.3 billion in proceeds from profitable investments, including the timely receipt of (a)
greater than $900 million repayments of well-structured and high unlevered IRR loans and (b) proceeds from the sale of non-core properties at an average 6% yield, redeploying the proceeds into future growth opportunities and improvement of
our balance sheet;
|
|
Value-Creating Investments:
|
|
Made investments of $800 million at a blended 7.5% cash yield to further improve the quality of our portfolio, including an acquisition of a premier independent living
seniors housing community located in the appealing Battery Park neighborhood of downtown Manhattan;
|
|
Research & Innovation Business Growth:
|
|
Elevated and expanded our Research & Innovation Business (grown by 45% since inception) with the nation’s leading research universities and created a $1.5 billion
development pipeline consisting of near-term projects with new and existing university relationships;
|
|
Successful Operator and Partner Collaborations:
|
|
Successful negotiation of collaborative and mutually beneficial arrangements with several of our operators and partners, including lease extensions with Brookdale and a
10-year extension of our exclusive MOB development relationship with PMB, which has nearly 50 years of experience in MOB development with top health systems in the U.S.;
|
|
2019 PROXY STATEMENT
|
83
|
Sustainability, Values, Reputation and Industry Leadership:
|
|
Published our high quality and well-received inaugural Corporate Sustainability Report, which provides transparency on our ESG
outcomes, actions and policies;
|
|
We were named among Fortune’s “World’s Most Admired Companies” and received numerous prestigious awards in 2018 in recognition of
our philanthropy, reputation, commitment to superior governance and results, industry leaders, exemplary stewardship and world-class team;
|
|
First REIT signatory to the CEO Action for Diversity & Inclusion™ pledge, a cross-industry CEO-driven business commitment to
advance diversity and inclusion in the workplace, and unconscious bias training was conducted for all employees;
|
|
Established and made public our Vendor Code of Conduct and Human Rights Policy;
|
|
Continued to build an industry-leading portfolio of 72 ENERGY STAR Certified buildings and 38 LEED Certified buildings, which
includes more than $430 million of investment in 8 active developments pursuing LEED certification and receipt of a broad range of awards and recognitions during the year in REIT space, healthcare industry and among global corporations,
including inclusion in the Dow Jones Sustainability Index (attaining top quartile results across ESG metrics among all North American real estate companies), achieving the #1 rank among public Healthcare REITs in the 2018 GRESB Real
Estate Assessment on Sustainability and representation in the FTSE4GOOD Sustainability Index Series;
|
|
Identified as a “Winning Company” in the 2020 Women on Boards Gender Diversity Index and a “Corporate Champion” by the Women’s Forum
of New York for having an industry-leading 33% female Board of Directors;
|
|
Ventas Charitable Foundation contributed greater than $900,000 to 78 organizations in 2018, including our ongoing 5-year, $1 million
marquee partnership with the Greater Chicago Food Depository to alleviate senior hunger; and
|
|
Greater than 90 percent of requests have been met and in excess of $670,000 given to an Employee Charitable
Fund, which provides grants to organizations that are directly nominated by our employees.
|
|
2019 PROXY STATEMENT
|
84
|
a brokerage statement or letter from your broker or custodian with respect to your ownership of shares of our common stock on March 15, 2019;
|
|
the Notice of Internet Availability of Proxy Materials;
|
|
a printout of the proxy distribution email (if you receive your materials electronically);
|
|
a proxy card;
|
|
a voting instruction form; or
|
|
a legal proxy provided by your broker, bank or custodian.
|
execute and return a later-dated proxy card before your proxy is voted at the Annual Meeting;
|
|
vote by telephone or over the Internet no later than 11:59 p.m. Eastern time on May 13, 2019;
|
|
deliver a written notice of revocation to our Corporate Secretary at our principal executive offices located at 353 North Clark Street, Suite 3300,
Chicago, Illinois 60654, before your proxy is voted at the Annual Meeting; or
|
|
attend the Annual Meeting and vote in person (attendance by itself will not revoke your prior vote by proxy).
|
|
2019 PROXY STATEMENT
|
85
|
|
2019 PROXY STATEMENT
|
86
|
as to each person proposed to be nominated for election as a director, all information relating to that person that would be required to be disclosed
in connection with the solicitation of proxies for election as a director pursuant to Section 14 of the Exchange Act;
|
|
as to each other item of business, a brief description of such business, the stockholder’s reasons for proposing such business and any material
interest that the stockholder or any of the stockholder’s associates may have in such business; and
|
|
as to the stockholder giving the notice, the stockholder’s associates and any proposed director-nominee: the name and address of such person; the
class, series and number of all shares of our capital stock owned by such person (and the name of the record holder, if beneficially owned), the date the shares were acquired and any short interest of such person in our securities;
whether and to what extent such person has engaged in any hedging or derivative transactions in our securities during the preceding 12 months; and the investment strategy or objective of such person.
|
By Order of the Board of Directors,
|
||
Debra A. Cafaro
Chairman and Chief Executive Officer
|
||
Chicago, Illinois
|
||
April 1, 2019
|
|
2019 PROXY STATEMENT
|
87
|
For the Year Ended December 31,
|
|||||||||
2018
|
2017
|
2016
|
|||||||
(In thousands, except per share data)
|
|||||||||
Net income attributable to common stockholders
|
$
|
409,467
|
$
|
1,356,470
|
$
|
649,231
|
|||
Net income attributable to common stockholders per share
|
$
|
1.14
|
$
|
3.78
|
$
|
1.86
|
|||
Adjustments:
|
|||||||||
Depreciation and amortization on real estate assets
|
913,537
|
881,088
|
891,985
|
||||||
Depreciation on real estate assets related to noncontrolling interests
|
(6,926)
|
(7,565)
|
(7,785)
|
||||||
Depreciation on real estate assets related to unconsolidated entities
|
1,977
|
4,231
|
5,754
|
||||||
Impairment on equity method investments
|
35,708
|
—
|
—
|
||||||
Gain on re-measurement of equity interest upon acquisition, net
|
—
|
(3,027)
|
—
|
||||||
Gain on real estate dispositions
|
(46,247)
|
(717,273)
|
(98,203)
|
||||||
Gain on real estate dispositions related to noncontrolling interests
|
1,508
|
18
|
—
|
||||||
Gain on real estate dispositions related to unconsolidated entities
|
(875)
|
(1,057)
|
(439)
|
||||||
Discontinued operations:
|
|||||||||
Loss on real estate dispositions
|
—
|
—
|
1
|
||||||
FFO (NAREIT) attributable to common stockholders
|
$
|
1,308,149
|
$
|
1,512,885
|
$
|
1,440,544
|
|||
FFO (NAREIT) attributable to common stockholders per share
|
$
|
3.64
|
$
|
4.22
|
$
|
4.13
|
|||
Adjustments:
|
|||||||||
Merger-related expenses, deal costs and re-audit costs
|
38,145
|
14,823
|
28,290
|
||||||
Non-cash income tax benefit
|
(18,427)
|
(22,387)
|
(34,227)
|
||||||
Impact of tax reform
|
(24,618)
|
(36,539)
|
—
|
||||||
Loss on extinguishment of debt, net
|
63,073
|
839
|
2,779
|
||||||
Gain on non-real estate dispositions related to unconsolidated entities
|
(2)
|
(39)
|
(557)
|
||||||
Change in fair value of financial instruments
|
(18)
|
(41)
|
62
|
||||||
Amortization of other intangibles
|
759
|
1,458
|
1,752
|
||||||
Other items related to unconsolidated entities
|
5,035
|
3,188
|
—
|
||||||
Non-cash charges related to lease terminations
|
21,299
|
—
|
—
|
||||||
Non-cash impact of changes to equity plan
|
4,830
|
5,453
|
—
|
||||||
Natural disaster expenses (recoveries), net
|
63,830
|
11,601
|
—
|
||||||
Normalized FFO attributable to common stockholders
|
$
|
1,462,055
|
$
|
1,491,241
|
$
|
1,438,643
|
|||
Normalized FFO attributable to common stockholders per share
|
$
|
4.07
|
$
|
4.16
|
$
|
4.13
|
|
2019 PROXY STATEMENT
|
A-1
|
|
2019 PROXY STATEMENT
|
A-2
|
For the Year Ended December 31,
|
||||||||
2018
|
2017
|
|||||||
(Dollars in thousands)
|
||||||||
Net income attributable to common stockholders
|
$
|
409,467
|
$
|
1,356,470
|
||||
Adjustments:
|
||||||||
Interest and other income
|
(24,892
|
)
|
(6,034
|
)
|
||||
Interest
|
442,497
|
448,196
|
||||||
Depreciation and amortization
|
919,639
|
887,948
|
||||||
General, administrative and professional fees
|
151,982
|
135,490
|
||||||
Loss on extinguishment of debt, net
|
58,254
|
754
|
||||||
Merger-related expenses and deal costs
|
30,547
|
10,535
|
||||||
Other
|
66,768
|
20,052
|
||||||
Loss from unconsolidated entities
|
55,034
|
561
|
||||||
Gain on real estate dispositions
|
(46,247
|
)
|
(717,273
|
)
|
||||
Income tax benefit
|
(39,953
|
)
|
(59,799
|
)
|
||||
Discontinued operations
|
10
|
110
|
||||||
Net income attributable to noncontrolling interests
|
6,514
|
4,642
|
||||||
Reported NOI
|
2,029,620
|
2,081,652
|
||||||
Adjustments:
|
||||||||
Modification fee
|
3,031
|
—
|
||||||
Normalizing adjustment for technology costs
|
648
|
3,375
|
||||||
NOI not included in same-store
|
(167,102
|
)
|
(222,354
|
)
|
||||
Straight-lining of rental income
|
13,396
|
(23,133
|
)
|
|||||
Non-cash rental income
|
(28,800
|
)
|
(17,700
|
)
|
||||
Non-segment NOI
|
(127,520
|
)
|
(119,208
|
)
|
||||
NOI impact from change in FX
|
—
|
713
|
||||||
(306,347
|
)
|
(378,307
|
)
|
|||||
Same-store cash NOI (USD)
|
$
|
1,723,273
|
$
|
1,703,345
|
||||
Percentage increase (USD)
|
1.2
|
%
|
|
2019 PROXY STATEMENT
|
A-3
|
Net income attributable to common stockholders
|
$
|
62,273
|
||
Adjustments:
|
||||
Interest
|
110,524
|
|||
Depreciation and amortization
|
244,276
|
|||
Non-cash stock-based compensation expense
|
9,202
|
|||
Loss on extinguishment of debt, net
|
7,843
|
|||
Gain on real estate dispositions
|
(10,354)
|
|||
Net income attributable to noncontrolling interests, net of consolidated joint venture partners’ share of EBITDA
|
(2,960)
|
|||
Loss from unconsolidated entities, net of Ventas share of EBITDA from unconsolidated entities
|
18,310
|
|||
Taxes (including tax amounts in general, administrative and professional fees)
|
(28,642)
|
|||
Change in fair value of financial instruments
|
(28)
|
|||
Unrealized foreign currency gains
|
(349)
|
|||
Merger-related expenses, deal costs and re-audit costs
|
4,322
|
|||
Natural disaster expenses (recoveries), net
|
54,895
|
|||
Adjusted EBITDA
|
469,312
|
|||
Pro forma adjustments for current period activity
|
3,384
|
|||
Adjusted Pro Forma EBITDA
|
$
|
472,696
|
||
Adjusted Pro Forma EBITDA, annualized
|
$
|
1,890,784
|
||
As of December 31, 2018:
|
||||
Total debt
|
$
|
10,733,699
|
||
Cash
|
(72,277)
|
|||
Restricted cash pertaining to debt
|
(28,669)
|
|||
Consolidated joint venture partners’ share of debt
|
(100,944)
|
|||
Ventas share of debt from unconsolidated entities
|
40,753
|
|||
Net debt
|
$
|
10,572,562
|
||
Net debt to Adjusted Pro Forma EBITDA
|
5.6
|
x
|
|
2019 PROXY STATEMENT
|
A-4
|